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ABSTRACT 
Background: Human Papilloma Virus (HPV) is the etiological agent in cervical cancer. 
There is a high prevalence of HPV infection among South African (SA) women, and cervical 
cancer is the second most common cancer among them. Two HPV vaccines, Cervarix and 
Gardasil, have recently been licensed for use in SA and models show that vaccination may 
lead to about 70% decline in cervical cancer cases. However, there is a need to know how to 
effectively promote and deliver the vaccines to ensure optimal uptake and coverage. Little 
research has been done in SA to describe women’s knowledge of HPV and cancer of the 
cervix. Moreover, the correlates and the predictors of women’s interests in receiving the HPV 
vaccine have not been characterized. It is therefore necessary to have locally obtained data 
which would guide the formulation of policies on the introduction and propagation of HPV 
vaccination in SA. 
Aim: The study aimed to describe the knowledge and awareness of HPV infection and 
vaccine of female university students and to determine the predictors of vaccine acceptability. 
Methodology: A cross-sectional survey on a stratified sample of 150 female students was 
conducted. Self-administered questionnaires were used to gather information on the students’ 
sexual behavior, awareness and knowledge about HPV infection and HPV vaccine and their 
health related beliefs. 
Analysis: Means and frequencies were used for descriptive analysis. Logistic regression was 
used assess to determine the predictors of willingness to be vaccinated. 
 
Results: The study found that 70% of the participants were sexually active. Awareness and 
knowledge on HPV/vaccine were poor; with only 22% being aware of HPV and that a HPV 
vaccine was available in South Africa. A greater proportion (80%) reported willingness to be 
vaccinated. Being aware of the existence of a pap smear, higher knowledge about HPV, 
higher perceived vaccine effectiveness and higher perceived severity of HPV infection were 
significantly associated with increased willingness to be vaccinated. 
Recommendations: There is need for education about HPV and vaccination in South Africa. 
An effective vaccine marketing strategy should emphasise the effectiveness of the vaccine, 
susceptibility to contracting HPV and its severity. Lobbying should also be done for the 
reduction in the cost of the vaccine. 
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Definition of Terms 
 
Human Papilloma Virus (HPV):  HPV is a member of the papilloma virus family of viruses 
that is capable of infecting humans and establish productive infections only in the stratified 
epithelium of the skin or mucous membranes (Schiffman and Castle, 2003). 
Cervical Intraepithelial Neoplasia (CIN):  CIN, also known as cervical dysplasia, is the 
potentially premalignant (precancerous) transformation and abnormal growth (dysplasia) of 
squamous cells on the surface of the cervix. Even though most cases of CIN remain stable, or 
are eliminated by the host's immune system without intervention, a small percentage of cases 
progress to become cervical cancer if left untreated (Kumar, Abbas, Fausto and Mitchell, 
2007). 
CIN 1: Is the least risky type, represents only mild dysplasia or abnormal cell growth and is 
confined to the basal 1/3 of the epithelium. It corresponds to infection with HPV, and 
typically will be cleared by immune response in a year or so, though can take several years to 
clear (Kumar et al., 2007). 
CIN 2: Moderate dysplasia confined to the basal 2/3 of the epithelium (Kumar et al., 2007). 
CIN 3: Severe dysplasia that spans more than 2/3 of the epithelium, and may involve the full 
thickness. This lesion may sometimes also be referred to as cervical carcinoma in situ (CIS) 
(Kumar et al., 2007). 
Cervical Cancer: It is a disease in which the cells of the cervix become abnormal and start to 
grow uncontrollably, forming tumours (Kumar et al., 2007). 
Model: A model can be thought of as a theory that is constructed to explain, predict and 
master phenomena such as events, or behavior of animals or humans (Ford, 2009). 
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Low grade squamous intraepithelial lesion (LSIL or LGSIL): usually indicates mild dysplasia 
and generally corresponds to the histological classification of CIN 1) (Apgar, Zoschnick and 
Wright, 2003). 
High grade squamous intraepithelial lesion (HSIL or HGSIL): indicates moderate or severe 
Cervical Intraepithelial Neoplasia or carcinoma in situ and generally corresponds to the 
histological classification of CIN 2 or 3 (Apgar et al., 2003). 
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Chapter 1: Introduction 
This study describes knowledge of female students about Human Papilloma Virus (HPV), 
cancer of the cervix (cervical cancer) and the predictors of HPV vaccine acceptability.  The 
first section of this chapter provides brief profiles of the country and the university. It 
discusses the pathological background of HPV, its causal link with cancer of the cervix and 
current ways of managing cervical disease. This is followed by a description of the burden of 
HPV infection and cancer of the cervix at global, regional and national levels. The statement 
of the problem, rationale of the study, relevant research questions as well as the hypotheses 
that were tested, are presented and then followed by a brief chapter summary and layout of 
the rest of the mini-thesis. 
1.1. South Africa  
Health indicators in South Africa are poor, with the heavy burden of HIV/AIDS reversing 
earlier improvements in life expectancy and mortality. The under-five mortality rate was 
reported to be 67 per 1 000 in 2000 while HIV/AIDS was the single most important cause 
accounting for 57% of these deaths (WHO, 2006). The same report estimated the maternal 
mortality ratio to be 230 per 100 000 live births. In 2002, AIDS ranked 1st among the top ten 
causes of death, accounting for 52% of the causes with cerobrovascular diseases coming 
second  (5%), and all the other causes accounting for less than 5% individually (WHO, 2002).  
1.2. The Profile of the University  
 At the time of the study (2009), this university∗ was serving a total of over 8,500 students 
(University Registrar’s office, 2009).  The University has five faculties namely: Education, 
Law, Management & Commerce, Science & Agriculture and Social Sciences & Humanities. 
In terms of student enrolment in 2009, Faculty of Social Sciences & Humanities was the 
largest with 2397 students followed by the Faculties of Management & Commerce, 
Education, Science & Agriculture and Law which had 2080, 1901, 1394 and 776 students 
respectively (University Registrar’s office, 2009). 
  
                                                           
∗
 Following a discussion by the university’s management at the time of data collection, it was agreed, for 
confidentiality reasons that throughout this thesis the researcher was not supposed to disclose the identity of 
the institution 
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Gender Distribution for 2008
 
Fig. 1: Gender distribution of students (University Registrar’s Office, 2009).     
 
Student Distribution by Race 2008
African-90%
White-7%
Colored-2%
Indian-1%
 
Fig. 2: Race distribution of students (University Registrar’s Office, 2009).     
 
The university enrolment, as shown in Fig. 2, is predominantly made up of African students. 
In 2008, the student distribution was 90% African, 7% white, 2% colored and Indian 1%. Fig. 
1 shows that in the same year, the gender distribution was 57% women vs. 43% men. In 
2008, undergraduate students (diploma, 3 or 4 year bachelors degrees) constituted the 
majority of the students as shown in figure 3. 
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Fig. 3: Student distribution by qualification type (University Registrar’s Office, 2009). 
1.3. Human Papilloma Virus 
Pathological Background 
Human Papilloma Virus (HPV) is a virus that is generally spread through skin-to-skin contact 
that occurs during sexual intercourse. However, in some cases, non-penetrative sexual contact 
can also lead to HPV infections (Winer, Lee, Hughes, Adam, Kiviat and Koutsky, 2003). 
There are over 30 strains of HPV that exist and infect the genital area (Daley, 1998; 
International Agency for Research on Cancer [IARC], 1995; Koutsky, 1997). 
Genital HPV infections are categorized by their association with cervical cancer (Daley, 
1998; IARC, 1995). Two HPV strains, types 6 and 11, categorized as low-risk types, can 
cause benign cervical cell changes and cause nearly all male and female genital wart 
infections. Human Papilloma Virus (HPV) is the etiological agent in cervical cancer and it 
has been shown to be a necessary but not a sufficient cause of cervical cancer (Munoz, 
Castellague, Berrington, Gonzalez and Gissmann, 2006).  
 
Approximately 20 HPV strains can cause cervical cancer in women (IARC, 1995). However, 
four are accountable for the majority of cases and known as high-risk types (IARC, 1995). 
The oncogenic or high risk types of HPV contain the E6 and E7 genes which code for the 
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tumour suppressor protein binding oncoproteins and are found in virtually all cases of 
invasive cervical cancer (Kirnbauer, 1996). Types 16 and 18 together, cause about 70% of 
cervical cancer, and Types 31 and 45 together cause another 15% (IARC, 1995; Hoover, 
Carfioli and Moench, 2000; Winer et al., 2003). Over 99% of cervical cancer cases result 
from genital infection with human papillomavirus (WHO, 2005). 
 
Table 1: Papillomavirus types involved in different human cancers (WHO, 2005) 
 
Type of Cancer Papillomavirus types involved          Percentage HPV Positive 
Cervical   16, 18, 31, 33, 35, 39, 45, 51, 58, 59, 66    >95 
Vulval   16, 18       >50 
Penile   16, 18       >50    
Vaginal  16, 18       >50 
Anal   16, 18       >70 
Oral Cavity  16, 18, 31      ~25 
Nail bed  16       ~75   
 
 
Infection with high-risk HPV is also associated with the growth of other malignancies (table 
1) including oral, vulva, penile and anal cancers (Castle, Schiffman, Bratti, Hildesheim, 
Herrero and Hutchinson, 2004; Gilson and Lowy, 2004). Frisch found that about 90% of anal 
cancers among women, 58% among heterosexual men, and 100% among homosexual men 
were positive for high-risk HPV DNA (Frisch, 2002). 
 
The association of HPV of the genitals with non-genital cancers (i.e. head, neck and 
esophageal cancers) has been less well established, but studies do support the possibility 
(Herrero, Castellsague, Pawlita, Lissowska, Kee and Balaram, 2003). 
 
Most individuals become infected during the first few years of initiating sexual activity, thus, 
it is common among adolescents or those in their early twenties (Berkow, Beers and Fletcher, 
1997; IARC, 1995; Harries, Moodley, Barone, Mall and Sinanovic, 2008). Most of the HPV 
 
 
 
 
6 
 
infections are asymptomatic. It has been shown that the median duration of the new infection 
is normally eight months; about 70% of new infections clear up within one year and 91% 
clear within two years (Franco, Villa, Sobrinho, Prado, Rousseau and Desy, 1999; Molano, 
Ven den Plummer, Weiderpass, Posso and Arslan, 2003). HPV cervical infection results in 
cervical morphological lesions ranging from normalcy (cytologically normal women) to 
different stages of precancerous lesions (CIN-1, CIN-2, CIN-3/CIS) and invasive cervical 
cancer. 
 
1.4. The development of cervical cancer 
Human papillomavirus (HPV) infection has been established as the necessary, but not solely 
sufficient, cause of cervical cancer (Walboomers, 1999). The vast majority of women 
infected with an oncogenic HPV type never develop cervical cancer, which suggests that 
additional factors acting in conjunction with HPV influence the risk of disease development. 
Rates of HPV infection spontaneously resolving on its own or progressing to cervical cancer 
without treatment vary for low-grade and high-grade cervical cell abnormalities. Low-grade 
cervical cell abnormalities typically resolve spontaneously (60%) and rarely progress to 
cancer (1%). However, without treatment, high-grade cervical cell abnormalities 
spontaneously resolve much less often (30-40%) and progress to cancer without treatment 
much more often (12%) (Ostor, 1993).  
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Table 2: Progression from HPV infection to cancer (Alliance for Cervical Cancer Prevention, 
2003). 
HPV Infection 
         
 
                        
Mild Cervical 
Dysplasia 
                                    
 
Severe Dysplasia 
                                
Cervical Cancer 
 
Infection is extremely 
common among 
women of 
reproductive age. 
 
Most cases remain 
stable or become 
undetectable. A small 
percentage of 
cases lead to 
abnormal 
cell changes (within 
months/years of 
Infection). 
These abnormal cell 
changes are usually 
temporary and 
disappear 
over time. 
 
Some cases, 
however, 
progress to severe 
dysplasia. 
 
 
The precursor to 
cervical cancer, 
severe dysplasia is 
far less common than 
mild dysplasia. 
 
Severe dysplasia can 
progress from mild 
dysplasia or, in some 
cases, directly from 
HPV infection. 
 
Invasive cancer 
develops 
over many years and 
is most common 
among women in 
their 50s and 60s. 
 
 
 
 
Progression to cervical cancer may not occur for 20 or more years after the first infection 
with HPV occurs, while genital warts normally appear one to six months later (IARC, 1995; 
Koutsky, 1997).  Co-factors such as parity, use of oral contraceptives, tobacco smoking, 
immune suppression particularly related to human immunodeficiency virus (HIV), infection 
with other sexually transmitted diseases, and poor nutrition have been associated to various 
extents with the development of invasive cervical cancer.  
 
1.5. Risk factors for progression to cancer 
A systematic review of eight case-control studies on invasive cervical cancer and two studies 
on carcinoma in situ (CIS) from four continents suggest that, compared to women who had 
never given birth, those with three or four full-term pregnancies had 2.6 times the risk of 
developing cervical cancer; women with seven or more births had 3.8 times the risk (Muñoz, 
Franceschi, and Bosetti, 2002). Other studies confirmed this positive correlation between 
high parity and cervical cancer (Brinton, Reeves and Brenes, 1989; Thomas, Qin and 
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Kuypers, 2001; Castellsague and Munoz, 2003). The physiologic reason for the association is 
unclear, but possibilities include hormonal factors related to pregnancy or cervical trauma. 
Evidence from research proposes that there is a potential long-term relationship between 
prolonged use of oral contraceptives and development of cervical cancer. Analysis of data 
pooled from ten case-control studies of patients with invasive cervical cancer or CIS suggest 
that long-term use of oral contraceptives could increase the risk of cervical cancer by up to 
four-fold in women with HPV infection (Moreno, Bosch and Munoz, 2002). Similar findings 
have been confirmed by other studies (Smith, Green, Berrington, Appleby, Peto and 
Plummer, 2003; Castellsague and Munoz, 2003). 
Smoking also appears to be strongly associated with the development of precancerous 
cervical lesions and cancer (Hildesheim, Herrero and Castle, 2001; Castellsague and Munoz, 
2003). It is among the most consistently identified environmental factors likely to influence 
the risk of cervical cancer. Studies show at least a two-fold risk for current smokers compared 
to non-smokers (Hildesheim et al., 2001; Szarewski and Cuzick, 1998; Castellsague, Bosch 
and Munoz, 2002). 
Women infected with HIV are more readily infected with high risk HPV types and are more 
likely to develop precancerous lesions (and develop them more rapidly) than HIV-negative 
women in the same age category (De Sanjose and Palefsky, 2002; Clarke and Chetty, 2002; 
Gaffikin, Ahmed, and Chen, 2003). Studies done in Africa confirmed the same findings 
(Parkin, Wabinga, Nambooze and Wabwire-Mangen, 1999; Sitas, Bezwoda and Levin, 
1997). 
Women who are co-infected with HPV and other sexually transmitted agents, such as 
Chlamydia trachomatis or herpes simplex virus-2 (HSV-2), are more likely to develop 
cervical cancer than   those who are not co-infected. One pooled analysis of seven case-
control studies examining the effect of HSV-2 infection in the etiology of invasive cervical 
cancer found that among HPV DNA-positive women, HSV-2 was associated with about a 
three-fold increased risk of developing cervical cancer after adjustment for potential 
confounders (Smith, Herrero and Bosetti, 2002). 
Low socio-economic status (SES) is recognized as a risk factor for many health problems, 
including cervical cancer, particularly in low-resource settings (Dos Santos and Beral, 1997). 
Women with low SES often have limited income, restricted access to health care services, 
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poor nutrition and a low level of awareness about health issues and preventive behavior. All 
of these factors can make them more vulnerable to illness and preventable diseases such as 
cervical cancer. 
 
1.6. Prevention/Management of cervical disease 
Such an in-depth knowledge about the natural history of the disease (cervical cancer) means 
that several ways to prevent the disease can be found. The precancerous changes in cervical 
tissue can linger for years, but if they are identified and successfully treated early, the lesions 
will not develop into cervical cancer (IARC, 1995). Thus, cancer of the cervix is a highly 
preventable disease which has primary and secondary levels of prevention (WHO, 2005).  
Primary prevention is supportive of efforts to increase public knowledge and the ability of 
individuals to make healthy lifestyle choices as well as creating environments that assist 
individuals in making healthy choices (Kaufman, Adam, Icenogle and Reeves, 1997). For 
instance, women should stop smoking or preferably never start smoking, use barrier methods 
during intercourse to prevent the spread of the HPV and other sexually transmitted diseases, 
postpone sexual activity to older age and decrease parity. Secondary prevention on the other 
hand, aims at early detection (screening) and treatment of precursors by the use of regular pap 
smears  (Alliance for Cervical Cancer Prevention, 2003). 
 
Table 3: Current ways of managing cervical disease (Alliance for Cervical Cancer 
Prevention, 2003). 
HPV Infection 
                               
Mild Cervical 
Dysplasia 
Severe Dysplasia Cervical Cancer 
There is no treatment 
to eliminate HPV. 
 
Mild dysplasia 
generally 
should be monitored 
rather than treated 
since 
most lesions do not 
progress to cancer. 
 
Severe dysplasia 
should 
be treated, as a 
significant 
proportion of cases 
progress to cancer. 
 
Treatment of 
invasive 
cancer is hospital-
based, 
expensive, and often 
not effective. 
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Traditional cervical cancer screening is based upon microscopic examination of cervical cells 
for abnormalities (Alliance for Cervical Cancer Prevention, 2003). Introduced in the 1950s, 
the Papanicolaou smear test, which involves scraping cells from the cervix, staining and 
examining them under a microscope, is one of the most successful cancer screening tools 
ever developed. With varying estimates of sensitivity and specificity, the test is not perfect. 
Yet between 1955 and 1992, deaths from cervical cancer in the US dropped by 74% as a 
direct result of the use of the Pap test in routine gynecological screening (Kaufman et al., 
1997).  
 
Most screening policies follow a triage system for detection, treatment, and follow-up of 
cervical abnormalities (Kaufman et al., 1997). Conservative triage schemes are based upon 
the assumption that most mild cervical abnormalities spontaneously regress to normal. Such 
schemes are, therefore, typically cautious about rushing into expensive treatments. In the UK 
for example, recommended policy states that women with a smear report indicating a ‘mild’ 
abnormality (LSIL: CIN1) should return for a second smear test in 6 months. If an 
abnormality appears again, immediate colposcopy is indicated. If the smear is negative and is 
followed by a second negative smear in 6 months time, she may return to a schedule of 
routine screening (Jenkins, Sherlaw-Johnson and Gallivan, 1996). 
 
More aggressive triage schemes are based upon the principal that ‘it’s better to be safe than 
sorry’ (Kaufman et al., 1997). The National Cancer Institute of the United States 
recommends that a woman with a mildly abnormal smear test should be re-screened in 3 
months, rather than 6. A second abnormal reading indicates that immediate colposcopy is 
warranted. If the follow up test is normal, she should be re-screened every 6 months. After at 
least three consecutively negative smears, she may then return to a routine schedule of annual 
tests (Kaufman et al., 1997).  
 
The South African cervical cancer-screening policy and the programme implemented since 
2001 attempts to reduce the incidence of cervical cancer by 70% (Department of Health, 
2003). Three free smears per lifetime are recommended for the program, commencing after 
the age of 30 and with a 10-year interval between each smear. 
 
Treatment of Cervical Intraepithelial Neoplasia (CIN) and invasive cervical cancer becomes 
progressively more complex and costly as severity of the lesion increases (WHO, 2005). CIN 
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can generally be treated by various methods of excision, but invasive cancer usually requires 
radiation, chemotherapy, or surgery (including cryosurgery, laser surgery, or hysterectomy). 
These higher levels of treatment are frequently uncomfortable for the patient and may involve 
many side effects. All women diagnosed and treated for CIN (1, 2, or 3) can expect to survive 
for at least 5 years. 80–90% of those diagnosed with stage I invasive cancer will survive for 
at least 5 years. Far fewer will survive after treatment for higher stages of invasive cancer; 
50–65% for stage II, 25–35% for stage III, and 0–15% for stage IV (Wolstenholme and 
Whynes, 1998). Though industrialized countries have greatly reduced deaths from cervical 
cancer through screening programmes that allow early detection and treatment, these 
programmes are expensive and difficult to implement in low-income countries such as those 
in Africa (WHO, 2005). It is these costs of treatment that may be avoided by introducing 
vaccination programmes. Thus, vaccines against HPV infections have the potential to be a 
more practical and cost–effective way to reduce the incidence of cervical cancer (WHO, 
2005).  
 
1.7. Burden of HPV infection  
Worldwide, about 10% of women in the general population are estimated to harbor cervical 
HPV infection at any given time (WHO, 2007), whilst 70% and 80% of women with low 
grade lesions and high grade lesions respectively test positively for HPV DNA (WHO, 2007). 
The same report shows that about 87% of all cervical cancers world wide tested positive for 
HPV DNA. Human Papillomavirus (HPV) infection is one of the most common types of 
sexually transmitted infections in the United States (Koutsky, 1997). The highest rates of 
HPV infection are found in adults aged 18-28 years (Koutsky, 1997). Research demonstrates 
that 10% to 39% of sexually active young women, especially those of college age (18-24 
years), are infected with high risk HPV at any point in time (Winer et al., 2003). 
South African women have a higher prevalence of HPV infection, with the highest rates of 
infection being found among the young sexually active adults under  the age of 25 (Allan et 
al., 2001). HPV type 16 (high risk) is the most dominant type found in South Africa 
(Williamson, Passmore, Marais and Rybicki, 2002).  About 15.5% of women in the general 
population are estimated to harbor cervical HPV infection at any given time, and 63.0% of 
invasive cervical cancers in South Africa are attributed to HPV types 16 and 18 (WHO, 
2007). 
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1.8. Burden of Cervical Cancer  
Cervical cancer has a major impact on the lives of women worldwide, particularly those in 
developing countries. According to the latest global estimates, 493,000 new cases of cervical 
cancer occur each year among women, with about 273,000 women dying of the disease 
annually (Tables 4 and 5). The disease represents a major health inequity as 83% of new 
cases (409 000) are in developing countries where screening programs are not well 
established or effective (Parkin, Whelan and Ferlay, 2002; WHO, 2005). In most of these 
countries, cervical cancer is the leading cause of cancer deaths among women. Central and 
South America, the Caribbean, sub-Saharan Africa, parts of Oceania, and parts of Asia have 
the highest incidence rates of over 30 per 100,000 women. These rates compare with no more 
than 10 per 100,000 women in North America and Europe (Parkin et al., 2002).  
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Table 4: Incidence of cervical cancer in South Africa, Southern Africa and the World 
 (Parkin et al., 2002)  
 
Indicator South Africa Southern Africa   World 
Crude Incidence Rate*    30.2   30.2   16 
Age-standardized Incidence Rate*    37.5   38.2   16.2 
Cumulative Risk (Age period 0-64yrs)      2.8     2.8   1.3 
Standardized Incidence Ratio (SIR)    226    229  100 
Annual number of new cases  6742 7698 493243 
 
* Rates are per 100 000 women 
 
 
Table 5: Mortality of cervical cancer in South Africa, Southern Africa and the World (Parkin 
et al., 2002).  
 
Indicator         South Africa        Southern Africa         World 
Crude Mortality Rate*   16.5  17.5   19 
Age-standardized Mortality Rate*  21  22.6    9  
Cumulative Risk (Age period 0-64yrs)   1.6    1.7    0.7 
Standardized Mortality Ratio (SMR)  234  252   100 
Annual number of deaths   3682  4455   273505 
 
 
 
* Rates are per 100 000 women 
 
Cervical cancer is the most common cancer in women in sub-Saharan Africa (Parkin, Ferlay 
and Hamdi-Cherif, 2003). An estimated 57,000 cases of cervical cancer occurred in the year 
2000, comprising 22.2% of all cancers in women, equivalent to an age-standardized 
incidence rate of 31 per 100,000 (Parkin et al., 2003). About 60–75% of women in sub-
Saharan Africa who develop cervical cancer live in rural areas, and mortality is very high 
(Parkin et al., 2003). Many of the women who develop cervical cancer are untreated, mostly 
due to lack of access (financial and geographical) to health care.  
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The age-specific incidence rate in black African populations in Harare was 55.0 per 100,000 
(Chokunonga, Levy and Bassett, 2002). Nonetheless, the true incidence of cervical cancer in 
many African countries is unknown as there is gross under-reporting (Anorlu, 2008). Only a  
few countries have functional cancer registries, and record-keeping is minimal or non-
existent. Some of the figures quoted in the literature are hospital-based, which represents a 
small fraction of women dying from cervical cancer, as most women cannot access hospital 
care and die at home. Women in sub-Saharan Africa lose more years to cervical cancer than 
to any other type of cancer (Anorlu, 2008). Unfortunately, it affects them at a time of life 
when they are critical to the social and economic stability of their families. 
Cervical cancer ranks as the most frequent cancer in the South African women between the 
ages of 15 and 44 (Parkin et al., 2002). South Africa has a population of 16.48 million 
women from 15 years and older, who are at risk of developing cervical cancer. In 2002, it 
was the leading cancer among South African women, with crude incidence and Age-
standardized incidence rates of 30.2 and 37.5 per 100 000 women respectively (Parkin et al., 
2002). In the same year, a total of more than 6700 new cases were reported (Tables 4 and 5). 
Cancer of the cervix has, since the beginning of the National Cancer Registry in 1986 in 
South Africa, been the leading cancer in black women (Mqoqi, Kellet, Sitas and Musa, 2004).  
In 2002, it was reported that black females had highest ASIR of 35 per 100 000 and 1 in 25 
women was at risk of developing cervical cancer (Parkin et al., 2002). The second highest 
rate of  26.4 per 100 000 in 1999 was recorded among colored women who comprised on 
average 7.5% of all cervical cancer cases reported,  whilst Asian women had the lowest 
cervix cancer incidence rates of 11 per 100 000 (Parkin et al., 2002). It is therefore worth 
noting that the lifetime risk of developing cervical cancer in black South African females was 
twice that of Asian females and 2.4 times that of colored and white females combined (South 
African Department of Health, 2003). 
The cancer of the cervix in colored and white women combined, constituted the second 
highest proportion (14%) to that in black women, with the lowest ASIR of 15.91 per 100 000. 
Asians had the least number of female cancer cases and had the second highest ASIR of 19 
per 100 000 (South African Department of Health, 2003). 
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1.9. Factors associated with high prevalence of cervical cancer in Southern Africa 
Socio-cultural factors 
The necessary cause of cervical cancer, Human papillomavirus (HPV), is endemic in Africa. 
Furthermore, many of the factors that increase both HPV acquisition and promote the 
oncogenic effect of the virus are also widespread in the continent. These include: early 
marriages, polygamous marriages and high parity. Polygamy is accepted in many societies in 
sub-Saharan Africa. In some cultures, very young girls (usually virgins), are given out to 
marriage to much older men, most of whom have already more than one wife (Bayo, Bosch 
and de Sanjose, 2002; Chaouki, Bosch and Munoz, 1998). This may increase the likelihood 
of a girl catching HPV infection at first intercourse with her husband. Polygamy is reported to 
increase the risk of cervical cancer two-fold and the risk increases with increasing number of 
wives (Bayo et al., 2002). 
 
Socio-economic factors  
Worldwide, women of low socio-economic status have a greater risk of cervical cancer. 
Cervical cancer is often referred to as a disease of poverty-striken women (Denny, 2005). 
Poverty is endemic in sub-Saharan Africa. A recent study in Mali in West Africa showed that 
within a population widely infected with HPV, poor social conditions, high parity and poor 
hygienic conditions were the main co-factors for cervical cancer (Bayo et al., 2002). Poverty, 
in its many ramifications, is also a very important barrier to the prevention and treatment of 
this disease. 
 
Biological factors 
Poor nutritional status and infections, e.g.malaria, HIV and TB, are ravaging sub-Saharan 
Africa and have made many people immuno-compromised (United Nations, 2008). 
Moreover, sub- Saharan Africa harbors about 70% of the world's population of people living 
with HIV and AIDS (United Nations, 2008). Several studies have demonstrated the 
association of HIV with HPV. A recently published study from Tanzania showed prevalence 
of HIV-1 was much higher among the cervical cancer patients (21.0%) than among the 
controls (11.6%) (Kahesa, Mwaiselage and Wabinga, 2008). The study reported that HIV-1 
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was a significant risk factor for cancer of the cervix (OR=2.9, 95% CI=1.4–5.9). It also 
showed that the mean ages of the HIV-1 positive and negative women with cervical cancer 
were 44.3 and 54 years respectively and this was a statistically significant finding 
(p=0.0001). Studies done in Zimbabwe and South Africa also suggested the association 
between HIV and cervical cancer (Chirenje, 2005; Moodley and Kleinschmidt, 2001). 
Recent studies have linked sexually transmitted infections (STIs) other than HPV, to cervical 
cancer (Hawes and Kiviat, 2002; Smith et al., 2002). These infections excite chronic 
inflammatory response which causes the generation of free radicals, which play an important 
role in the generation and progression of cancers (Hawes and Kiviat, 2002). Unfortunately, 
many women who get these infections receive incomplete treatment, because they cannot 
access (financially or geographically) good health care, thereby making chronic and 
persistent infections very common. 
 
1.10. HPV vaccine  
 Since it became evident that HPV has a role in the genesis of cervical cancer, vaccines 
against HPV infections have been developed, and a massive push for vaccination is underway 
world-wide (Wong, 2008; WHO, 2006). This includes the two new prophylactic HPV 
vaccines namely: a bivalent vaccine targeting HPV16 and 18 (Cervarix; GlaxoSmithKline) 
and a quadrivalent vaccine targeting HPV 16, 18, 6 and 11 (Gardasil; Merck, Sharpe and 
Dohme). The vaccines are designed to enhance the immune response and increase the 
duration of protection against cancer-causing virus types.  
Preliminary results show that the quadrivalent vaccine is efficacious in preventing the 
infections and diseases caused by the types of HPV covered by the vaccine and is well 
tolerated (Centre of Disease Control [CDC], 2007). The bivalent vaccine has also been shown 
to be efficacious and well tolerated in women over 26 years of age (Schwarz and Dubin, 
2007; Schwarz, Spaczynski and Schneider, 2009). Studies have shown that the HPV vaccine 
is a highly cost-effective health intervention (Goldie, Kohli, Grima, Wienstein, Wright and 
Bosch, 2004). Modelling studies have shown that if fully implemented, vaccination may lead 
to 31% percent reduction in pre-cancerous lesions which translate to about 68% decline in 
cervical cancer cases (Alliance for Cervical Cancer Prevention, 2003). 
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The vaccine is currently registered and already in use in more than 50 countries across 
Europe, Australasia and South America. In the UK, routine HPV vaccination is now offered 
to all girls age 12-13 years, with a ‘catch-up’ for adolescent girls up to 18 (Marlow, Waller, 
Evans and Wardle, 2008). Both vaccines have been licensed for use in SA in March 2008 but 
they are not yet available in the public health sector (Harries et al., 2008). An important 
component to this study was a cost-effectiveness analysis of integrating cervical cancer 
prevention programmes by adding the HPV vaccine to the existing screening programme in 
the public sector. The study reported that that adding a vaccine to the current screening 
programme to prevent HPV related diseases in South Africa is a cost-effective strategy 
(Harries et al., 2008). 
 
1.11. Problem Statement  
The recent development of two prophylactic HPV vaccines offers great potential for primary 
prevention of cervical cancer in South Africa. However, as with any new product, there are 
many questions about how best to promote and deliver the vaccines to ensure optimal 
population coverage. Acceptability of the vaccine, owing to the sexually-transmitted nature 
of HPV, has been recognized as one of the keys to ensuring widespread immunization.  
A significant body of literature exists about issues relating to HPV vaccine acceptability. 
However, these studies focus on awareness and knowledge about cervical cancer, HPV and 
HPV vaccine in relation to potential uptake and resistance in developed countries. To date, 
little has been done in developing countries and in particular, in South Africa where the 
knowledge and awareness of HPV might be different from developed countries. Equally 
important is the fact that the predictors of women’s interest in HPV education and receiving 
the HPV vaccine has not been characterized in this country where a significant number can 
benefit from vaccination. Hence, it is necessary to have locally obtained data if it is to be of 
any use in guiding the formulation of policies which will be implemented in the introduction 
and propagation of HPV vaccination in South Africa. 
 
1.12. Rationale of the study 
Research demonstrates that about 10% to 39% of sexually active young adult women (ages 
18-25) are infected with high risk HPV at any point in time (Koutsky, 1997; Alan et al., 
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2001; Winer et al., 2003). Since the majority of university students are of the above 
mentioned age group, they can be used as a proxy for this high risk group. In addition, 
university students may be potential social influencers in their own communities, because of 
their potential to attain higher education and social status. It is also noteworthy that female 
students will soon be mothers (if not already so) and are more likely to play a key role in 
HPV vaccination in the future if the universal vaccination of 11–12-year-old girls is 
recommended in South Africa, as has been the case in other countries (Markowitz, Dunne 
and Saraiya, 2007). This is largely due to the fact that people often infer others’ needs from 
their own needs and beliefs and thus one may assume that women would infer their 
daughters’ needs for HPV vaccination based on their perceived needs (Serpell and Green, 
2006).  
 
1.13. Aim of the study  
The aim of the study is to investigate the knowledge and awareness of HPV infection among 
female university students and their intent to receive the HPV vaccine. 
Objectives 
1) To determine the level of HPV infection awareness among female university students. 
2) To describe the knowledge of HPV infection and cervical cancer among the students. 
3) To describe the HPV vaccine awareness among the students. 
4) To describe the attitudes and beliefs of female university students towards the HPV 
infection and vaccine. 
5) To analyze correlates and predictors of vaccine uptake. 
 
1.15. Hypotheses 
The Health Belief Model (HBM) codifies attitudes and beliefs that motivate vaccination 
(Brewer, Weinstein, Cuite and Herrington, 2004; Chapman and Coups, 1999; Becker, 1974). 
The model suggests that key predictors for acceptability of any vaccine include perceived 
disease likelihood and severity, perceived vaccine benefits and barriers, and cues to action. In 
the context of HPV vaccination, perceived likelihood is the belief that HPV infection and 
cervical cancer are likely outcomes. Perceived severity is the belief that HPV infection and 
cervical cancer would have serious negative health consequences. Perceived vaccine 
effectiveness (i.e. perceived benefit) is the belief that the HPV vaccine will reduce the risk of 
HPV infection or cervical cancer. Perceived barriers can be any perceived impediments to 
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vaccination, such as cost. Cues to action are situational and social factors that prompt one to 
get vaccinated. 
The following hypotheses were tested in analysis: 
H1: Individuals with low perceived severity to HPV infection would not be willing to be 
vaccinated. 
H2: People with low perceived susceptibility to HPV infection would not be willing to be 
vaccinated. 
H3: Participants with low perceived benefits to prevent HPV would not be willing to be 
vaccinated. 
 
Chapter layout 
This Chapter 1 provided the background to the study. It reviewed the pathological 
background of the Human Papilloma virus and highlighted the causal link between HPV and 
cancer of the cervix. It also described the burden of HPV infections and cervical cancer 
globally, within Southern Africa and South Africa.  
 
Chapter 2 focuses on a review of relevant literature pertaining to this study. Both local and 
global studies are reviewed and an overview of the theoretical frameworks including the one 
that is utilized in this study.  
 
Chapter 3 Outlines the methodology used in this study.  
 
Chapter 4 Presents the results of the study.   
 
Chapter 5 Discusses the results in reference to the literature, providing some possible 
explanations for the findings. 
 
Chapter 6 Summarizes   the findings and provides recommendations, based on the findings of 
the study.  
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Chapter 2: Literature Review 
 
This review is presented in three parts. In the first part, global and national studies on 
awareness and knowledge of HPV infection or cancer of the cervix are reviewed. In the 
second part, a discussion of five theories of health behaviour, which offer predictions about 
the uptake of HPV vaccination, is given. In the third part, a review of studies on factors 
influencing HPV vaccine uptake is given. It is worth noting that this third part is based on 
studies that used Health Belief Model constructs as predictors of HPV vaccine acceptability. 
 
A significant body of literature and interest has emerged over the past ten years around HPV 
vaccine acceptability (Klug, Hukelmann and Blettner, 2008). These studies focused mainly 
on HPV knowledge and attitudes towards HPV vaccination in relation to uptake or potential 
opposition (Klug et al., 2008). Awareness and knowledge about HPV infection, cervical 
cancer and HPV vaccines are prerequisites for making informed decisions about vaccination 
(Kahn, Rosenthal, Hamann and Bernstein, 2003; Gerend, Lee and Shepherd, 2007; Zimet, 
Mays, Sturm, Ravert, Perkins and Juliar, 2005). 
 
2.1. Awareness of HPV 
Awareness about HPV infection has been found to vary considerably, with the proportions of 
respondents who have heard of HPV ranging between 13% and 93% (Klug et al., 2008). A 
rigorous study among a representative group of sexually active college women in USA found 
that 13% of them were aware of HPV (Vail-Smith and White, 1992). The level of awareness 
has been found to be higher among women attending gynecological clinics, as was reported 
in a study of 1032 respondents attending a woman’s wellness clinic in London (25%) 
(Waller, McCafeffery and Forrest, 2003). A similar trend has been confirmed  by Giles and 
Garland (2006) who found that 73% and 93% of Australian women visiting university health 
service and attending cervical dysplasia clinic, respectively, although this convenient sample 
was small (n=60) and not representative of the study population. Higher awareness also tend 
to be reported in studies that included women only; suggesting that women are more aware of 
HPV than men (Waller et al., 2003; Yacobi, Tennant, Ferrante, Pal and Roetzheim, 1999). 
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2.3. Knowledge about HPV 
Reported knowledge about HPV varies, with studies reporting between 8% and 68% of 
respondents being aware of the association between HPV and cervical cancer (Klug et al., 
2008). An e-mail survey in Iceland found that 34% of the respondents  (60% response rate, n 
= 250) knew that HPV is a risk factor for cervical cancer (Gudmundsdottir, Tryggvadottir, 
Allende, Mast, Briem and Sigurdsson, 2003). However, when assessed using an open-ended 
question, knowledge about HPV was found to be consistently lower (between 0.6–11%) 
(Waller, McCaffery and Wardle, 2004; Pitts and Clarke, 2002; Baay, Verhoeven, Avonts and 
Vermorken, 2004; Klug, Hetzer and Blettner, 2005).  
 
Health professionals had considerably more knowledge about HPV than other population 
groups and between 82–100% of physicians knew that HPV is a risk factor for cervical 
cancer (Chingang, Bischof, Andall-Brereton and Razum, 2005; Irwin, Montano and 
Kasprzyk, 2006; Baay, Verhoeven, Peremans, Avonts and Vermorken, 2006). Teachers and 
nurses in middle and high schools in Vermont, USA, had less knowledge than physicians, 
with only half aware that HPV is a causal agent for cervical cancer (Beatty, O'Connell, 
Ashikaga and Cooper, 2003).  
  
Two large representative studies in the UK (Waller et al., 2004; Wardle, Waller, Brunswick 
and Jarvis, 2001) and one among first year university students in the USA (Baer, Allen and 
Braun, 2000) found that women are more knowledgeable about HPV (knowing that HPV is a 
risk factor for cervical cancer; and  that HPV is transmitted by skin-to-skin contact) than 
men.  
The existence of genital warts was well known among most study participants, in stark 
contrast to the casual link between HPV and the cancer of the cervix (Ramirez, Ramos, 
Clayton, Kanowitz and Moscicki, 1997). Studies report that more than 88% of their 
respondents had heard of genital warts (Ramirez et al., 1997; 2000; Baer et al., 2000; 
Holcomb, Bailey, Crawford and Ruffin, 2004).  Other studies report that between 5–64% of 
study participants knew that HPV can cause genital warts (Baer et al., 2000; Holcomb et al., 
2004; Moreira, Oliveira, Ferraz, Costa, Costa Filho and Karic, 2006; Waller et al., 2003).  
HPV is often confused with other sexually transmitted infections, such as the human 
immunodeficiency virus (HIV) and herpes simplex virus (Baer et al., 2000; Holcomb et al., 
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2004; Ramirez et al., 1997; Yacobi et al., 1999). Ramirez et al. (1997) report in their study 
that 53% of university students in USA believed that HPV was related to the “AIDS virus” 
(HIV). Other studies found that 20% of the university students in the USA thought that 
herpes was a symptom of an HPV infection (Yacobi et al., 1999), and 67% of patients 
attending family private practice in the USA were unsure whether genital herpes was a 
symptom of HPV infection (Holcomb et al., 2004).  
Despite the above mentioned inadequacies in knowledge about HPV, Klug et al. (2008) note 
that the level of knowledge is improving with more recent studies (see Fig. 4).  Klug and 
colleagues performed linear regression of six robust studies on knowledge about HPV as a 
risk factor for cervical cancer to examine the influence of the year the study was done on 
knowledge of HPV infection. They found that the year of study conduct was positively 
correlated with knowledge (Spearman's correlation coefficient=0.38) and this may imply that 
people are becoming more aware of this important infection. 
 
Fig 4: Linear regression-knowledge by year of study conduct. Source: (Klug et al., 2008). 
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There is limited published research on the awareness and knowledge of HPV in South Africa. 
A cross-sectional survey of female students at the Walter Sisulu University (formerly 
University of Transkei) investigated their awareness of cervical cancer and its risk factors 
(Buga, 1998). The results of this study showed that 68% of the respondents were aware of the 
casual link between HPV and cancer of the cervix. This figure is quite high when compared 
to figures reported from other studies in developed countries.  
 
A study in three districts of South Africa found that awareness of a pap smear (which can be 
used as a proxy for the awareness of HPV infection or cervical cancer) among women 
attending clinics varied widely depending on the race and level of income (Moodley, 
Kawonga, Bradley and Hoffman, 2006). In an urban district near Cape Town, made up of 
predominantly colored people of middle income, 95% of the participants were aware of a pap 
smear whilst only 10% of mainly black women in a low income rural district of Limpopo had 
ever heard of a pap smear. The same study reports that in district made up of mainly an urban 
informal settlement in Johannesburg, 33% of the clinic attendees had heard of pap smear.  
 
Harries and colleagues (2008) conducted a qualitative study to explore key challenges and 
opinions towards HPV vaccination in three diverse areas in the Western Cape Province. 
Focus group discussions were carried out with women aged 21 - 57 years who had children 
who would be eligible for the HPV vaccine. Women’s levels of knowledge and 
understanding of cervical cancer, the causative relationship between HPV and cervical 
cancer, and the purpose and preventive nature of pap smears, were found to be poor. The 
study reports that many knew of the availability of cervical screening services but did not 
fully understand the purpose of pap smears. Some associated pap smears with ‘cleansing or 
scraping the womb’, after possible exposure to a sexually transmitted infection, after having 
been raped or, in other instances, to ensure fertility. 
 
2.4. Theories to predict vaccine uptake 
A number of health psychology theories exist to explain health-related behaviors such as 
vaccination and guide interventions designed to promote vaccination (Becker, 1974; 
Chapman and Coups, 1999). These theories of health behavior can offer predictions about 
beliefs likely to increase adoption of the HPV vaccine. I will review five theories, namely the 
Game theory, Extended Parallel Processing Model, Framing Theory, Theory of Planned 
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Behavior and Health Belief Model as they have been noted to guide the introduction and 
propagation of vaccination interventions (Ajzen, 2006; Arnett, 2000; Hawe, Mckenzie and 
Scurry, 1998; Weerasinghe, Fernandes and Bagaria, 2007; Tversky and Khaneman, 1981). 
 
2.4.1. The game theory 
 
The game theory explicitly formalizes the relationship between individual decision-making 
processes and population dynamics (Bauch, Galvani and Earn, 2003).  Though originally 
used to predict the economic behavior of people by Von Neumann and Morgenstern (1944), 
it can be used to relate population-level demand for vaccines to decision-making by 
individuals with varied beliefs about the costs of infection and vaccination (Reluga, Bauch 
and Galvani, 2006). The individual’s decision to receive vaccination decreases their own risk 
of infection, as well as the risk for those people with whom they interact (Cullen and West, 
1979). There exists an interplay between vaccine coverage, disease prevalence and the 
vaccinating behavior of individuals, through the emergence of herd immunity (i.e. the 
probability that an individual becomes infected depends upon how many other individuals are 
vaccinated) (Bauch and Earn, 2004). The value of vaccination to a community is greater than 
the sum of the benefits accrued by each individual (Cullen and West, 1979). Hence, in 
deciding whether to vaccinate their children, parents consider the risk of morbidity from 
vaccination, the probability that their child will become infected, and the risk of morbidity 
from such an infection. The decisions of individual parents are indirectly influenced by the 
decisions of all other parents, because the sum of these decisions yields the vaccine coverage 
levels in the population and hence, the course of the epidemic (Bauch et al., 2003). Inversely, 
if everyone around them is vaccinated, they may be tempted not to vaccinate thinking that 
their child is protected through herd immunity. In this case, a slight perceived risk can tip the 
scales in favor of non vaccinating behavior and cause a decline in vaccine uptake. 
 
The game theory attempts to predict individual behavior in such a setting, where the payoff to 
strategies chosen by individuals depends on the strategies adopted by others in the 
population. To understand this potentially complex interplay, a game dynamic model is 
developed in which individuals adopt strategies according to an imitation dynamic (i.e. a 
learning process), and base vaccination decisions on disease prevalence and perceived risks 
of vaccines and disease (Reluga et al., 2006). Though the detailed mathematical formulae of 
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the model is beyond the scope of this study, in simple terms, the model predicts that 
oscillations (i.e. up and downs) in vaccine uptake are more likely in populations where 
individuals imitate others more readily or where vaccinating behavior is more sensitive to 
changes in disease prevalence (Bauch and Earn, 2004). Oscillations are also more likely 
when the perceived risk of vaccines is high.  
 
Reluga et al. (2006) explain that when vaccine supply cannot satisfy demand, vaccine uptake 
will be stable. However, when the vaccine is in abundant supply, the dynamics of vaccine 
uptake depend on the individual’s perceived utilities of vaccination and vaccine refusal and 
upon infection prevalence. When the utility (i.e. the perceived difference between benefits 
and costs) of vaccination is small and refusal is preferred even when infection is endemic, 
nobody will choose to vaccinate, and the dynamics are the same as those that would occur in 
the absence of vaccination.  
 
When the utility of vaccination is large, vaccination is preferred even when the infection is 
absent from the population and the majority of the population will choose to vaccinate 
(Bauch and Earn, 2004).  A large vaccination utility then implies that the vaccination 
coverage will be stable and sufficient for eradication. In some cases, the utility of vaccination 
will lie between these extremes: when the infection is endemic, individuals may prefer 
vaccination, but when the infection is rare, individuals may prefer not to risk vaccination 
(Reluga et al., 2006). When prevalence is low, individuals place greater value on refusal, and 
when prevalence is high, individuals place greater value on vaccination. 
 
This model reproduces salient features of the time evolution of vaccine uptake and disease 
prevalence during the whole-cell pertussis vaccine scare in England and Wales during the 
1970s (Reluga et al., 2006; Weerasinghe et al., 2007). This suggests that using game 
theoretical models to predict the population dynamics of vaccinating behavior may be 
plausible. 
 
2.4.2. Extended Parallel Processing Model  
The Extended Parallel Processing model offers a framework for investigating attitudes 
toward the HPV vaccine and thus the effectiveness of fear appeals (Witte, Cameron, McKeon 
and Berkowitz, 1996) (Figure 5). It emphasizes that there are two general responses to health 
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and risk messages. People can adopt a “Danger Control Process” (DCP) in which they work 
to lower danger and fear by, for example, receiving the vaccine or stopping risky practices. 
This behavior indicates a cognitive process. On the other hand, people may choose to adopt 
the “Fear Control Process” (FCP). When people adopt this process, they attempt to minimize 
the associated problem by, for example, saying that the problem has been blown out of 
proportion. This is considered an emotional response. Optimistic bias of health hazards is a 
particularly common FCP and needs specific methods to combat it. For instance, in order to 
understand the best way to handle the propagation of large scale HPV vaccination in South 
Africa, we have to understand the role that optimistic bias plays. Optimistic bias explains the 
phenomenon that people are more likely to think that their own personal risk of a particular 
danger is less than that of their peers (Weinstein, 1989). The obstacle of optimistic bias can in 
many cases be difficult to overcome (Weinstein and Klein, 1995).  
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Fig 5: The Extended Parallel Processing Model (Witte et al., 1996). 
Optimistic bias has been shown to be a factor in a number of different health risks. For 
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there was a significant amount of optimistic bias regarding one’s own chances of contracting 
HIV (Hardeman, Pierro and Mannetti, 1997). It is thus plausible that in the current scenario 
of HPV vaccination, some individuals may perceive their risk of HPV infection as so low that 
it may not warrant them receiving the vaccine. 
Some factors that may lead toward an optimal DCP include response-efficacy - the perception 
that the actions a person takes can minimize a threat - and self-efficacy - the idea that people 
believe they are able to perform the recommended actions. Factors that may lead toward the 
less desirable FCP include perceived severity and susceptibility. If you believe that the 
danger is severe and unavoidable, you are more likely to adopt an FCP. Understanding these 
different processes is vital in determining whether a specific health campaign is likely to be 
effective.  
 
2.4.3. Framing theory 
A frame in social theory consists of a schema of interpretation that individuals rely on to 
understand and respond to events (De Martino, Kumaran, Seymour and Dolan, 2006). 
Framing refers to the social construction of a social phenomenon by mass media sources or 
specific political or social movements or organizations (De Martino et al., 2006). It is an 
inevitable process of selective influence over the individual's perception of the meanings 
attributed to words or phrases. A frame defines the packaging of an element of rhetoric in 
such a way as to encourage certain interpretations and to discourage others. 
Framing effects arise because one can frequently frame a decision using multiple scenarios, 
wherein one may express benefits either as a relative risk reduction (RRR) or absolute risk 
reduction (ARR) (De Martino et al., 2006). Extrinsic control over the cognitive distinctions 
(between risk tolerance and reward anticipation) adopted by decision makers can occur 
through altering the presentation of relative risks and absolute benefits. People generally 
prefer the absolute certainty inherent in a positive framing-effect, which offers an assurance 
of gains (Tversky and Khaneman, 1981). When decision-options appear framed as a likely 
gain, risk-averse choices predominate. On the other hand, a shift toward risk-seeking 
behavior occurs when a decision-maker frames decisions in negative terms or adopts a 
negative framing effect. 
 
 
 
 
28 
 
A much cited example demonstrating the power of framing is provided by Kahneman and 
Tversky (1981) in their research on heuristics. They gave experimental subjects the following 
statement: 
"Imagine that the U.S. is preparing for the outbreak of an unusual Asian disease, 
which is expected to kill 600 people. Two alternative programs to combat the disease 
have been proposed. Assume that the exact scientific estimates of the consequences of 
the programs are as, follows: If Program A is adopted, 200 people will be saved. If 
program B is adopted, there is a one-third probability that 600 people will be saved 
and a two thirds probability that no people will be saved. Which of the two programs 
would you favor?" (Tversky and Khaneman, 1981: 455). 
The results were as follows: 78 chose Program A; 22 chose Program B. However, when the 
wording was altered so that the consequences remained the same but referred instead to the 
number of deaths (e.g. If Program A is adopted, then 400 people will die), the results were 
nearly reversed. 
In a similar way information on vaccination can be presented (framed) in such a way as to 
increase its uptake. Three basic frames have been described namely Gain-framed (i.e. 
emphasizing the advantages of getting vaccine), Loss-framed (i.e. emphasizing the 
disadvantages of not getting vaccine) and a Non-framed control where information only 
provided. Smith and Petty (1996) propose that gain-framed messages are more effective in 
improving vaccine uptake when compared to non framed controls. 
Thus, in the context of HPV vaccination, we may predict that a gain framed message such as:  
 
Angela felt very healthy and didn't believe she would be infected by the HPV.  But she 
followed the advice of the South African Medical Association and got 3 HPV vaccine shots 
over 6 months. Because of this, she is protected against HPV infection.  Now she is much 
less likely to get sick or die from serious cancer of the cervix, and she can look forward to a 
long and healthy life, watching her child grow up. 
 
will more likely yield a greater vaccine uptake than a non-framed control message such as: 
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We want to remind you that hepatitis HPV can be transmitted by unprotected sex. A vaccine 
for HPV exists. It requires 3 shots over 6 months to be most effective at preventing infection 
with the HPV. 
 
 2.4.4. Theory of Planned Behavior (TPB) 
The Theory of Planned Behavior (TPB) is based on the notion that since getting vaccinated is 
a discrete behavior, it may be amenable to simple, brief persuasive message interventions. 
The TPB of Icek Ajzen helps us to understand how we can change the behavior of people 
(Ajzen, 1991). It is a theory which predicts deliberate behavior because behavior can be 
planned. The TPB is a successor of a similar Theory of Reasoned Action (Ajzen and 
Fishbein, 1975; Ajzen and Fishbein, 1980). The success was a result of the discovery that 
behavior appeared to be not 100% voluntary and under control. This resulted in the addition 
of Perceived Behavioral Control and with this addition it was called the Theory of Planned 
Behavior. 
In short, according to TPB, human action is guided by three kinds of considerations explained 
below. Behavioral Beliefs, which are beliefs about the likely consequences of the behavior. 
Normative Beliefs, which are the perceived behavioral expectations of such important referent 
individuals or groups as the person's spouse, family, friends, and depending on the population 
and behavior studied teacher, doctor, supervisor, and co-workers. Finally, Control Beliefs, 
which basically entail beliefs about the presence of factors that may facilitate or impede the 
performance of the behavior.  
 
These three considerations are crucial in circumstances or programmes where the behaviour 
of people needs to be changed. In their respective aggregates, Behavioral Beliefs produce a 
favorable or unfavorable attitude towards the behavior; Normative Beliefs result in perceived 
social pressure to engage or not to engage in a behavior or subjective norms; whilst Control 
Beliefs give rise to perceived behavioral control which refers to people's perceptions of their 
ability to perform a given behavior (Ajzen, 2006). 
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Fig 6: The Theory of Planned Behavior (Ajzen, 2006). 
 
In combination, attitudes towards the behavior, subjective norms and perceived behavioral 
control lead to the formation of behavioral intention (Ajzen, 1991). Intention is an indication 
of a person's readiness to perform a given behavior, and it is considered to be the immediate 
antecedent of behavior. As a general rule, if the attitude and subjective norm are favorable, 
the perceived control will be greater and the person’s intention to perform the behavior in 
question, say vaccination, should be stronger. This theory may help us explain why 
advertizing campaigns merely providing information may sometimes not work. Increasing   
knowledge only does not help change the behavior very much. Campaigns that target 
attitudes, perceived norms and control in making the change may be more likely to have 
better results. 
 
2.4.5. The Health Belief Model 
Becker (1974) developed the concepts of the health belief model (HBM). Health belief is 
based upon the idea that an individual must have the willingness to participate in health 
interventions and believe that being healthy is a highly valued outcome. Therefore, it may be 
possible to predict if an individual would engage in positive health behaviors by determining 
the individuals’ perception of the disease, illness or accident, identification of modifying 
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factors, and the likelihood that the individual will take some action. The most influential 
factor that might prevent an individual from engaging in healthy behaviors is the perceived 
barriers (Bastable, 1997). Becker’s model can be presented diagrammatically as shown in 
figure 7. 
Individual Perceptions             Modifying Factors                                  Likelihood of Action         
Perceived Susceptibility 
┼ 
Perceived Seriousness 
             
Demographic, Socio-
psychological  and Structural 
Variables Perceived Barriers  
 
Cues to Action:  
Advice from others  
Reminders form Primary Care  
Articles or TV information  
Illness of friend or family 
member 
Perceived Benefits 
           ┼ 
Perceived Barriers 
  
 
Perceived Threat of Disease 
                    
                  
 
 
 
Likelihood of Taking 
Recommended  
Preventive Health 
Action  
 
 
 
Fig 7: The Health Belief Model (Bastable, 1997:135) 
 
In the context of HPV vaccination, perceived likelihood is the belief that HPV infection and 
cervical cancer are likely outcomes. Perceived severity is the belief that HPV infection and 
cervical cancer would have serious negative health consequences. Perceived vaccine 
effectiveness (i.e., perceived benefit) is the belief that the HPV vaccine will reduce the risk of 
HPV infection or cervical cancer. Perceived barriers can be any perceived impediments to 
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vaccination, such as cost. Cues to action are situational and social factors that prompt one to 
get vaccinated.   
It is noteworthy mentioning that many of the attitudes and beliefs that motivate influenza and 
other vaccination behaviors are codified in the health belief model (HBM) (Brewer et al., 
2004; Chapman and Coups, 1999; Becker, 1974). It is also interesting to note that 
interventions guided by the health belief model have been shown to increase vaccination rates 
(Hawe et al., 1998; Larson, Bergman, Heidrich, Alvin and Schneeweiss, 1982).  
Nonetheless, even though the above theories were put forward by different authors at 
different time settings, they are similar in one way or the other. For instance, the facts that 
individuals will consider risk of morbidity from vaccination and risk of morbidity from the 
disease as stated in the Game Theory are the equivalents of the constructs of perceived 
barriers and perceived severity as put forward in the Health Belief Model. In a similar 
manner, the concepts of normative beliefs and control beliefs in the TBP theory are similar to 
the constructs of cues to action and perceived self-efficacy as highlighted in the HBM. 
 
2.5. Intention to take up HPV vaccine 
Globally, the findings of both qualitative and quantitative research strongly suggest that most 
women have positive attitudes about receipt of a HPV vaccine (Baykal, Al and Ugur, 2008; 
Donders, Gabrovska and Bellen, 2008; Fazekas, Brewer and Smith, 2008; Gerend et al., 2007 
and Lee, Kwan and Tam, 2007). The highest rate of acceptability (96%) was found among 
urban Turkish women aged 17 to 35 years, recruited from an obstetrics and gynecology clinic 
(Baykal et al., 2008). The lowest rate was found among urban women in Belgium, where 
only half of the respondents (also sampled from obstetrics/gynecology clinics) indicated 
intention to be vaccinated (Donders et al., 2008).  
2.5.1. Vaccine acceptability among individuals 
Attitudes regarding HPV vaccine acceptance can be assessed based on acceptability of 
previous vaccines and surveying patients, parents and health care providers. Kahn and 
colleagues surveyed 52 young women who were attending medical clinics in the US 
regarding HPV vaccination, and they found that most viewed vaccination positively (Kahn et 
al., 2003). Most of the respondents (98%) reported intention to receive the vaccine for 
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themselves and their hypothetical daughters. The same study found that knowledge of HPV 
and the vaccine, personal beliefs about vaccination, beliefs that others would approve of 
vaccination, higher number of sexual partners, and perceived support of provider, partner and 
parents, were all significantly associated with the intention to receive the vaccine. 
 In another study of 256 college students, 74% endorsed HPV vaccination (Boehner, Howe, 
Bernstein and Rosenthal, 2003). Of those surveyed, acceptance was significantly correlated 
with higher number of sexual partners, parental support, endorsement of universal HPV 
vaccination, low cost, and vaccine safety.  Similar findings were reported by a study which 
examined the attitudes about hypothetical HPV vaccines in adolescent (n = 20) and adult 
women (n = 20) attending two urban STI clinics in Indianapolis, United States (Zimet, Mays 
and Fortenberry, 2000). The study found that the idea of an HPV vaccine was favorably 
received. Several factors affected potential acceptance, including vaccine efficacy, physician 
endorsement as well as cost. 
 
2.5.2. Vaccine acceptability among parents 
Vaccine acceptance among parents is not universal. Concern over potential side-effects from 
vaccines is a common barrier to vaccination (Taylor, Darden, Brooks, Hendricks, 
Wasserman, and Bocian, 2002). Parents may also object to vaccination for religious or 
philosophical reasons (Diekema, 2005). The sexual nature of HPV infections may introduce 
unique barriers to parental consent not previously encountered with other vaccines. For 
instance, parents may feel that consenting to a vaccine for an STI may inadvertently 
encourage their adolescent children to engage in sexual intercourse (Davis, Dickman, Ferris 
and Dias, 2004). Concomitantly, some parents might think that vaccination at an early age 
will encourage earlier sexual debuts. 
Contrary to the above mentioned findings, other studies suggested that the sexually 
transmitted nature of HPV may not pose a major obstacle to HPV vaccine acceptance. In one 
study conducted by Mays and workmates, 70% of parents approved of vaccination for STIs 
(Mays, Sturm and Zimet, 2004). The same study found that desire to protect their children, 
concern about specific disease characteristics, and personal experience with an STI were 
directly correlated with vaccine acceptance. It also reported that rejection of the vaccine was 
associated with the perception that their child was at low risk for infection or with the parent 
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having a low concern about severity of the disease. It is worth noting that both of these 
reasons for refusal of the vaccine are codified in the concepts or constructs of the Game 
theory and HBM. 
In a similar study, Zimet and colleagues questioned 278 parents about their attitudes towards 
adolescent vaccination, incorporating nine hypothetical STI scenarios defined along four 
different dimensions: mode of transmission (STI vs non-STI), severity 
(curable/chronic/fatal), vaccine efficacy (50%, 70%, 90%), and behavioral method for 
prevention (available/not available) (Zimet et al., 2005). Interestingly, the study reported that 
whether a disease was sexually transmitted or not, did not affect the parents’ decision. 
Instead, severity of the hypothetical disease and vaccine efficacy predicted vaccine 
acceptance, which is in agreement with the HBM constructs of perceived severity and 
perceived benefits respectively (Zimet et al., 2005). 
When parents who were undecided about HPV vaccination were provided with a basic 
information sheet about HPV and HPV vaccines, they became significantly more likely to 
support HPV vaccination (Davis et al., 2004). This may imply that failure to take up the HPV 
vaccine due to lack of knowledge may be overcome by giving potential recipients adequate 
information about the vaccine before asking them to be vaccinated. Physician endorsement 
and school requirements have also been identified as important catalysts for parental vaccine 
acceptance (Zimet et al., 2005). Again, these findings are in line with the concept of 
normative beliefs and the construct of cues to action which are clearly spelt out in the TBP 
theory and HBM respectively. 
 
2.6. Predictors of vaccine uptake 
The constructs in the health belief model - perceived risk, perceived effectiveness of the 
vaccine, perceived barriers to vaccination, and cues to action - are among the most important 
predictors of influenza vaccination (Becker, 1974; Chapman and Coups, 1999). A number of 
studies assessing HPV vaccine acceptability among female have been carried out using 
beliefs based on the Health Belief Model, and the constructs of this model has been shown to 
predict vaccine uptake among females. 
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Perceived likelihood  
Between 21% and 46% of adolescents and young adult respondents perceived themselves to 
have some chance of being infected with HPV (Ramirez et al., 1997; Yacobi et al., 1999). 
Similarly, adult women reported high perceived chances of getting cervical cancer (Anhang, 
Wright, Smock and Goldie, 2004; Kahn et al., 2003). Higher perceived likelihood of HPV 
exposure or infection was related to higher vaccine acceptability (Boehner et al., 2003; 
Friedman and Shepeard, 2006; Olshen, Woods, Austin, Luskin, and Bauchner, 2005). The 
association between perceived likelihood of getting cervical cancer (as distinct from HPV 
infection) and HPV vaccine acceptability was also reported in a study by Gerend and 
colleagues among females recruited from community health clinics in the USA (Gerend, Lee 
and Shepherd, 2006). 
Perceived severity 
Studies show that women believed cervical cancer is a health problem with severe 
consequences (Anhang et al., 2004; Kahn et al., 2003; Mays et al., 2004). However three 
studies reported that higher perceived severity of HPV infections or cervical cancer was not 
related to greater vaccine acceptability (Boehner et al., 2003; Kahn et al., 2003; Dempsey, 
Zimet, Davis and Koutsky, 2006). This is despite the fact that one study highlighted that 
perceived severity was the second most influential factor in rating the acceptability of 
sexually transmitted infection vaccines among parents (Zimet et al., 2005). There is a dearth 
of literature on the relationship between perceived severity of cervical cancer (as distinct 
from HPV infection) and HPV vaccine acceptability. 
Perceived effectiveness 
Although no published studies reported mean levels of perceived vaccine effectiveness, 
higher perceived effectiveness was associated with greater HPV vaccination intentions for 
both parents of adolescents and adults in three studies (Davis et al., 2004; Dempsey et al., 
2006; Zimet et al., 2005). In the study by Zimet and friends, parents rated vaccine 
effectiveness as the most important attribute of an acceptable sexually transmitted infection 
vaccine (Zimet et al., 2005). Furthermore, perceived effectiveness of the vaccine, specifically 
against HPV infection, predicted vaccine acceptability in one study (Gerend et al., 2006). 
However there is paucity of published studies reporting on the role of perceived effectiveness 
of the vaccine against genital warts or cervical cancer in acceptability. 
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Barriers 
As mentioned previously, concern among parents that vaccination could promote adolescent 
sexual activity is a barrier to HPV vaccination. In the four studies that quantified how 
common this concern was, only 6% to 12% of parents endorsed it (Constantine and Jerman, 
2007; Davis et al., 2004; Mays et al., 2004; Zimet et al., 2005). On the other hand, two 
qualitative studies that did not quantify how common this theme was, reported that parents 
had strong concerns that administering the HPV vaccine would implicitly condone youth 
sexual behaviors (Friedman and Shepeard, 2006; Olshen et al., 2005). 
Cost is a commonly stated barrier to receiving the HPV vaccine (Boehner et al., 2003; 
Friedman and Shepeard, 2006; Zimet et al., 2005; Hoover at al., 2000). Low perceived 
vaccine safety is another barrier to vaccination (Constantine and Jerman, 2007; Boehner et 
al., 2003; Dempsey et al., 2006). One study reported that getting multiple shots was not a 
barrier to vaccination (Gerend et al., 2006). Anticipated side effects from the HPV vaccine 
such as pain or discomfort are also reasons for low acceptability (Davis et al., 2004; 
Dempsey et al., 2006). 
Situational and social factors that influence vaccine uptake 
HPV vaccine acceptability was higher among parents and young adults who believed that 
their physician would recommend  it (Boehner et al., 2003; Davis et al., 2004; Dempsey et 
al., 2006; Gerend et al., 2006; Kahn et al., 2003; Olshen et al., 2005), but few studies 
reported the frequency of this belief. Additionally, parents who opposed the HPV vaccine 
were less likely to be influenced by physician recommendations than parents who were more 
accepting of the vaccine (Davis et al., 2004). School requirements for children to receive the 
HPV vaccine were associated with higher acceptability of the HPV vaccine (Davis et al., 
2004). 
Demographics 
Studies report that other factors other than the HBM constructs such as age and marital status 
have been associated with vaccine acceptability. Two studies found that vaccine acceptability 
decreased with age (Marshall, Ryan and Roberton, 2007; Baykal et al., 2008). It may be due 
to the fact that some older women believe that it is too late for them to get the vaccine 
(Fazekas et al., 2008). Other studies found that, compared to women in polygamous 
relationships, married women and those in monogamous relationships viewed HPV 
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vaccination as less acceptable (Kahn et al., 2003; Marshall et al., 2007; Fazekas et al., 2008).  
The reason for this could be  that these women see themselves at relatively low risk for HPV 
infection and thus, are less likely to be interested in vaccination.  Interestingly, two studies 
found no statistically significant association between age or marital status to vaccine 
acceptability (Khan et al., 2003; Baykal et al., 2008). This may indicate that these clearly 
defined demographic factors are not determinants of attitudes about HPV vaccine. 
 Experience with HPV related conditions 
Women’s historical/behavioral experiences related to HPV may play a role in vaccine 
acceptability. The relationship of abnormal pap smears with vaccine acceptability was 
inconsistent with some studies finding a link (Ferris, Waller, and Owen, 2008), while others 
finding no relationship (Gerend et al., 2007; Baykal et al., 2008).  
Knowledge about HPV 
Studies reported mixed findings about the relationship of HPV knowledge to vaccine 
acceptability (Boehner et al., 2003; Dempsey et al., 2006; Kahn et al., 2003). One 
educational intervention presented brief factual information on HPV increased vaccine 
acceptability (Davis et al., 2004).  However, because changes in knowledge were not 
reported, the study findings cannot be tied to knowledge with any certainty (Davis et al., 
2004). Limited knowledge and awareness of HPV make it difficult for some people to discuss 
HPV vaccine acceptability (Friedman and Shepeard, 2006; Olshen et al., 2005). Even so, 
HPV vaccine acceptability is high despite generally low levels of HPV knowledge (Harries et 
al., 2008; Wong, 2008). 
There has been rather limited research on the acceptability of the HPV vaccines in South 
Africa. A recent qualitative study in Western Cape Province investigated the key challenges 
and barriers towards the introduction of HPV vaccination (Harries et al., 2008). Fifty in-depth 
interviews and six focus groups were conducted with policy makers, health care workers and 
ordinary members of the community. Harries and colleagues reported that the need for a 
vaccine to prevent cancer resonated with all respondents including community members. This 
was despite the overall poor community knowledge of cancer of the cervix. Also, the causal 
relationship between cervical cancer and HPV was noticed amongst the respondents. In 
addition, the potential barriers to vaccine uptake namely: cost and concerns about increased 
sexual activity following vaccination, were raised by the respondents. It was proposed that 
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they could be circumvented by giving the vaccine free of charge and marketing the vaccine as 
a preventive measure for cancer, rather than taking it as a preventive measure for sexually 
transmitted infections.  
 
2.7. Summary 
In this chapter, it has been shown that world wide awareness and knowledge of HPV 
infection are generally limited. However people seem to be more aware of genital warts than 
the causal link between HPV and cancer of the cervix. A number of theories exist which can 
be used to guide vaccination interventions in order to maximize uptake of the HPV vaccines. 
Vaccination interventions guided by the Health Belief Model have been shown to greatly 
improve vaccination rates. Generally, it is reported that the public have positive attitudes 
towards the HPV vaccine. A number of factors which may predict vaccine uptake have been 
characterized. However, a cause for concern is the paucity of studies done locally to describe 
awareness and knowledge of HPV within the general population. Equally important is the 
fact that little has been done in South Africa, to describe the attitudes towards HPV vaccine 
and assess predictors of vaccine uptake. 
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Chapter 3: Research Methodology 
  
3.1. Study design  
A quantitative, cross-sectional survey of female students at a South African University was 
conducted to describe their knowledge about Human Papilloma Virus (HPV), cancer of the 
cervix, HPV vaccine and factors that influence HPV vaccine acceptability among them. 
 
 I opted for a cross-sectional survey design for this project as it was ideal for descriptive 
epidemiology to answer the so-called “descriptive pentad of Who, What, Why, Where and 
When” (Grimes and Schulz, 2002:145). In a descriptive study, a phenomenon is described or 
the relationship between variables is explained (Rothman, 1986). A survey, by definition, 
provides data about the present and indicates what people are thinking, planning and doing 
(Polit and Hungler, 1999). Thus, I used a survey for this study to describe the prevailing 
situation regarding HPV and vaccine knowledge among the students and their intention to 
receive HPV education and vaccine. Hence, it was best suited to answer the objectives (1, 2 
and 3 as mentioned in chapter 1) of the study. 
 
Although generally distinguished from a case-control study, a cross-sectional study can be 
thought of as a case-control analogue of a population cohort study (Rothman, 1986). Thus, 
the design is an analytical study. This positive spin-off allowed logistic regression to be used 
to determine the predictors of interest in HPV education and correlates of HPV vaccine 
acceptability thus, answering the fifth objective of the study. Another advantage was that 
since both predictors (exposures) and outcomes (dependents) were ascertained at the same 
time (the defining feature of a cross-sectional study), it was less time consuming and the costs 
involved were smaller. This also meant that loss to follow-up was not a problem and that 
fewer ethical difficulties existed. Consequently, it was relatively easier to carry out the study. 
3.2. Study Population 
The study or target population can be defined as: “the entire specific aggregate of cases 
about which the researcher would want to make generalizations” (Granziano and Raulin, 
2000: 133). For the purposes of this study, the target population was composed of all the 
female students registered at the University during 2009 and attending lectures at the time of 
the study.  
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3.3. Sampling  
Researchers do not often study the entire target population due to time and cost constraints 
and thus, a portion of the target population is subjected to research (Leedy, 1997). A sample 
may thus be defined as that portion which is selected to represent the study or target 
population (Fitzpatrick, 1999).  For the purposes of this study, it was those female students 
who were chosen to take part in the study. 
 
The sample size was guided by the requirement to measure the percentage of participants 
who were aware of HPV or cervical cancer. Given that there were about 5000 registered 
female students at the university, on the basis of the most conservative estimate that 20% of 
them were aware of HPV/cervical cancer, allowing 15% or 25% as the worst acceptable 
values and a 95% confidence interval, the required sample size that was calculated to be 150 
using the Epi info 2007 version (Stat Calc).  
 
Sampling refers to the process of selecting a portion (sample) from the target population in 
order to gather data that represent the target population (Fitzpatrick, 1999). A sample is 
considered to be representative of the target population if all the members of the target 
population have an equal chance of forming part of the sample (Pollit and Hungler, 1999). 
The concept of randomness or probability sampling is central to the process of obtaining a 
representative sample (Leedy, 1997). Also, a representative sample makes it possible for the 
findings of the study to be generalized to the target population (Leedy, 1997). 
 
Since I sought to generalize the findings of the study to the female student body at the 
university, I employed a stratified random sampling method to obtain a representative sample 
of the female students. Each of the five faculties was considered to be a homogeneous 
stratum. A random sample of 30 participants was then selected from each faculty. Stratified 
sampling was employed mainly as a means of saving time and money because the target 
population was spread out, and I could not sample from everywhere. Consequently, the 
survey was easier to administer operationally. Other trade offs of this method of sampling 
were firstly, a potential for greater information yield as I could obtain statistics within each 
strata as well as of the whole sample and secondly, that stratified random sampling can 
markedly improve the precision of estimators especially if the strata are homogenous by 
reducing the variance of the estimates (Pollit and Hungler, 1999). 
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3.4. Data Collection 
The data collection was done after the University of the Western Cape’s Research and Ethics 
Committee had approved the research proposal and the Registrar of the University had 
granted permission for the research to be done. I then sought assistance from the five faculty 
officers to randomly sent emails (based on student numbers) to 60 email addresses belonging 
to female students registered in each of the five faculties. Each e-mail invited the student to 
participate in a “female health awareness study” by filling a 5 minute questionnaire which 
was available on request at their prospective faculty office and get two vouchers for free 
lunch and supper. In addition to this, flyers advertising the study were put near entrances of 
the faculty offices. 
 
 Self-administered, anonymous, confidential questionnaires, consisting of close ended 
questions were used to collect information. In each faculty office, the interested participants 
were issued with an information sheet which they read and signed before completing an 
attached questionnaire to show their informed consent. The information sheet explained the 
purpose of survey and gave detailed information to the study participants on their rights as 
enshrined in the Human Sciences Research Council’s (HSRC) ethical guidelines (HSRC, 
2009). It also reminded them to ask for assistance on anything that they did not understand. 
After completing the questionnaire, students were asked to place questionnaires in box 
located in the faculty officer. General knowledge HPV pamphlets (published by the Cancer 
Association of South Africa [CANSA]) were placed next to the questionnaire box for 
students to take at will (CANSA, 2009).  At the end of each day,  I  would go to the five 
offices to collect the completed questionnaires until 30 were filled in each of the faculty. It 
took two and half weeks for me to get the required number of completed questionnaires. 
 
The Survey Instrument 
Stone and Campbell highlight that a questionnaire can be standardized and this increase the 
reliability, comparability and precision of data from one region or time frame to another 
(Stone and Campbell, 1984).  They also note that it allows the data to be quantified and thus, 
aggregate results can be presented concisely. In addition, because the data collected is 
structured, statistical methods can be applied to asses the relationships between the variables 
measured (Pollit and Hungler, 1999). The questionnaire is also inexpensive (no extensive 
training is required to administer it) and can be quickly administered if distributed to a group 
of participants which is in keeping with snap shot aspect of a cross sectional study design 
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(Grimes and Schulz, 2002). The fact that the questionnaire was self-administered minimized 
issues of confidentiality which were particularly important in this study, where sensitive 
issues like sexual activity were asked. Its close ended nature meant that exact responses were 
obtained which in turn, were easy to code and analyze. I therefore wanted to capitalize on 
these advantages of questionnaires in this study. 
 
The questionnaire (survey instrument) used in this study was a modified version of the 
Knowledge and Perceptions Survey (KAPs). The KAPs instrument, which is a standardized 
questionnaire, was designed by McPartland and colleagues to asses perceived severity, 
susceptibility, knowledge of HPV and intent to practice HPV preventative health behavior 
(McPartland, Weaver and Koutsky, 2005). Questions to examine knowledge of existence of 
HPV vaccine, perceived barriers, perceived benefits and self efficacy to take up more HPV 
education and HPV vaccination were incorporated in KAPs for the purpose of this study. 
Each HBM variable was operationalized via a 4-point Likert scale. In addition, questions on 
participants’ number of sexual partners in the last 12 months and their intent to take up more 
HPV education and vaccination in order to prevent HPV infection were added. Demographic 
characteristics included age, level of study at the university and ethnic background (Appendix 
3). 
 
3.5. Pilot Study 
A pilot study is the collection of data before the main study is executed (Leedy, 1997). The 
rationale of the pilot study was to determine whether the survey instrument was clearly 
worded, free from biases, solicited the information that was required. It was also important in 
assessing the time requirements for completing the questionnaire and detecting any other 
unforeseen flaws or gross inadequacies before the full scale study was embarked upon 
(Fitzpatrick, 1999; Pollit and Hungler, 1999).  
 
A pilot study was done by distributing 10 questionnaires to 10 female students who were in 
the main library. After they had completed filling the questionnaires, I asked them to engage 
in some verbal discussion to elicit some feed back on ways to improve the survey instrument.   
I however requested them not to participate in the full scale study which was due to run in the 
following two months. Analysis of the pilot study data was also done and sent to the 
supervisor before embarking on the main study. 
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Changes to be made to the data collection tool based on the Pilot Study 
Question number 2 which asked the ethnicity (e.g. Xhosa, Zulu e.t.c.) of the respondents was 
changed to be two questions: one simply asking whether the respondent was black, white, 
Asian or colored and another which asked whether the student was a SA citizen or not. This 
is because I realized during the pilot study, that some respondents were non SA citizens and 
hence could not identify themselves with any of ethnic groups that were listed. This led to 
some of them leaving the question blank. Question number 3, which asked about the current 
level of study, was similarly split into two: one asking for the level and another stating the 
faculty in which the student was learning.  
Based on the feedback received from the participants, I noted that though most of them had 
heard of cancer of cervix or Pap smear before, they were not aware of the term HPV. This 
prompted me to expand the “awareness” question number 8 to three which all specifically 
asked whether the participant has heard of HPV, Cancer of the cervix or Pap smear 
separately. 
  
The pilot analysis revealed that the HPV knowledge question number 12 was often left blank 
by quite a significant number of the participants. Oral feedback from  them showed that some 
of the questions were not familiar with them and the answers “true” or “false” made it 
difficult to answer, to such an extend that some even just guessed as they felt obliged to say 
something. The final version of the questionnaire included an option of “not sure”. Since one 
of the main objectives of the study was to determine the participants attitudes and beliefs 
towards the HPV vaccine, and given the apparent limited knowledge of the subject of matter 
(HPV) among the participants,  I  had to modify Section C of the questionnaire ( i.e. Health 
related beliefs section). This was achieved by inserting some more information about HPV in 
bold at the beginning of the section i.e.: “HPV is a sexually transmitted virus that can cause 
genital warts or cancer of the cervix. The following are specific questions about an HPV 
vaccine that has been developed to prevent HPV Infection, genital warts and cancer of the 
cervix. I am interested in how people might feel about this vaccine.  So for now, please 
pretend the vaccine is available”. By giving the respondents this basic information,  I  hoped 
this allayed the fears that those who had little information about the subject matter  could still 
go ahead and complete this section as they   then  had some basic understanding of what was 
being expected of them. 
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Despite the challenges described above, a number of positive findings were noted during the 
pilot study. For instance, all the participants finished completing the questionnaires in 
5minutes, proving that the time requirements were as previously expected. This was quite 
encouraging given the fact that the study was conducted in the month of November when 
students are usually busy preparing for their end of year examinations hence, would want a 
questionnaire which took the minimum amount of time from their busy schedule. More over, 
all of the participants completed all the questions requesting sensitive information regarding 
their sexual life thus, allaying my fears that some of these questions eliciting invaluable 
information might be left blank thus potentially affecting the outcome of the study. 
 
3.6. Data analysis 
 
3.6.1. Coding 
The questionnaires were given numbers (from 1 up 150). This gave them a unique 
identification number which made it easier for each set of electronic data to be traceable to 
the original questionnaire. Race was coded into a categorical variable: Black (1), White (2), 
Colored (3) and Asian/Indian (4). The citizenship status was coded into a dichotomous 
variable: SA (South African) and Non-SA (not a South African). 
 
 Knowledge of the HPV infection and HPV vaccine was coded and analyzed as follows: Each 
correct response was coded (2), each incorrect attempt was coded (1) and (0) was coded for 
those who were not sure. To get the total knowledge score for each participant, one point was 
awarded for every correct answer and zero for incorrect or the ‘not sure’ responses. This total 
knowledge score was then converted into a dichotomous knowledge variable by using the 
define and assign functions of Epi info 2007 version. Low knowledge was below mean score 
and high knowledge was any score above the mean of total knowledge score as in 
McPartland and colleagues (McPartland et al., 2005). Code 1 was given for “high” and 0 for 
“low”. 
 
Other information was coded as follows: 1 was given for ‘yes’ and 0 for ‘no’ unless 
otherwise stated. However, for number of sexual partners, 1 was given for those that reported 
more than 1 partner, and zero for those with 1 or no partners. Source of information was 
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coded into a categorical variable: Media (1), Friends and Family members (2) and Health 
care professionals (3). 
 
All constructs of the HBM were turned into dichotomous variables for the purpose of data 
analysis. For instance, intent to take up HPV education the answers “not at all likely” and 
“fairly likely” were recorded as 0 (no intention to take up vaccination) and answers “very 
likely” and “definitely likely” were recorded as 1 (intention to be educated about HPV). All 
other variables using likert scales were coded in a similar fashion. 
  
3.6.2. Cleaning 
Obvious data entry error such as outliers (really high or low numbers) e.g. .age=220 (really 
22 or 20), values which were entered but did not exist for the variable (for instance if sexually 
active) and any missing values were checked for and corrected using the original 
questionnaire. Double entry was done. This entailed entering the data twice into Epi Info, 
then comparing both data sets by the Data Compare function for discrepancies. Any 
differences between the two data sets were checked up and appropriately corrected using the 
original questionnaire. Univariate data analysis (i.e. exploring each variable in the data set 
with box plots) was used to check the quality of the data. Box plots were used to check if the 
maximum and minimum values made sense, and also to see if all subjects had data or if some 
values were missing. Inconsistencies or unexpected results were investigated and corrected 
using the original questionnaire.  
 
3.6.3. Statistical Analysis 
The Epi info 2007 version was used to analyze the data. There were two main outcome 
variables in this study: participants’ intent to take up HPV education and their willingness to 
be vaccinated. There were six main predictor variables; each of the five HBM constructs 
(namely: perceived severity of HPV infection, perceived likelihood of HPV infection, 
perceived effectiveness of the HPV vaccine, perceived barriers to HPV vaccination, cues to 
HPV vaccination) and the participants’ score on the HPV/cervical  cancer knowledge. Other 
variables that were assessed and treated as predictor variables were; participants’ ethnic 
background, whether they are sexually active, whether they are in a relationship, number of 
sexual partners in the last 12 months and if they used a condom in their last sexual encounter. 
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For descriptive analysis means and standard deviations were calculated for continuous 
variables such as age and the HPV/cervical cancer knowledge score, whilst frequencies were 
computed for categorical variables such level of study and racial background.  
 
In addition, simple and multivariate logistic regression analysis was performed to assess the 
relationship between predictor variables with each of the outcome variables whilst 
concurrently adjusting for confounding using a p-value of 0.05.  
 
3.7. Validity 
 Brewer defines internal validity of a study as an assessment of how well the study measures 
what it seeks to measure (Brewer, 2006). To ensure high internal validity of the study the 
researcher did the following: 
The questionnaire was pilot tested on 10 subjects to establish questionnaire logistics, time 
frame, skip patterns and replace vague or confusing questions. The subjects were asked to 
complete the questionnaire and provide feed back questions. Face validity was examined by 
cervical cancer specialist and public health educator. The feedback obtained from these 
sources was used to develop the final version of the survey instrument as described in Section 
3.5 above. 
 
Confounding or blurring of effects, which is another form of bias and a threat to internal 
validity, was controlled by the multiple logistic regression method during data analysis. This 
is a multivariate technique which allowed me to determine the effect of level of HPV 
knowledge on the willingness to be vaccinated whilst controlling (i.e. keeping them constant) 
for the other covariates such as age and sexual behavior which can be potential confounders. 
 
As a way of ensuring a high degree external validity, which is the ability to extrapolate the 
findings to the study population, a representative sample was selected by probability 
sampling (Mitchell and Jolly, 2001). Moreover, a high participation rate was encouraged by 
making the students complete the questionnaires at their own free time thus minimizing the 
disruption of their studies. Offering them free lunch and supper vouchers as well as assuring 
the participants that the data would be confidential also motivated them. 
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3.8. Reliability 
Reliability is a measure of reproducibility of a survey instrument (Shadish, Cook and 
Campbell, 2004).  It describes the precision or random error of the instrument (Shadish et al., 
2004). To improve reliability, participants completed a modified version of a self-
administered questionnaire called the Knowledge and Perceptions Survey (KAPS). The 
KAPS is a standardized instrument which was originally designed by McPartland and his 
colleagues in 2005 to assess perceived severity, susceptibility, knowledge of HPV, and intent 
to change behavior among college-aged students (McPartland et al., 2005). The knowledge 
scale of the KAPS had high internal consistency (Crohnbach’s alpha=0.93) in a study 
conducted by Yacobi and colleagues among university students (Yacobi et al., 1999). Study 
manuals were also available for both my assistant and I to refer to for guidance any time that 
problems arose during data collection. 
 
3.9. Generalizabilty 
The results of this study could only be generalised to the study population. However, it is 
anticipated that the findings will have relevance more in this country as the Department of 
Health embarks on wide scale introduction of HPV vaccination.  
 
3.10. Ethics 
Ethical approval by the University of the Western Cape’s Research and Ethics committee was 
sought and permission to conduct the research amongst university students had to be granted 
by the Registrar of the university before the research commenced. Given the sensitivity of 
this research, which requested for some aspects of the private life of university students, I 
guaranteed that the basic principles of human research ethics (respect of persons, 
beneficence, non-malevolence, voluntary participation, confidentiality and justice) will be 
safeguarded (Human Sciences Research Council, 2009). 
 
This research will be of a great benefit to the females of South Africa, as recommendations 
on promoting HPV vaccination will be made to the ministry of health. Participation in this 
study did not result in any harm to the participants. On the other hand, declining to participate 
in the study did not result in any harm to those who refused to participate. Participation in the 
study was voluntary and participants were given an option to answer only the questions they 
felt comfortable with. Also, they could withdraw from the study at any time. Those who 
wished to withdraw were instructed to simply not answer any further questions but to remain 
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in their seats until the end. In this way, they could withdraw anonymously. The use of 
anonymous self-administered closed questions guaranteed the respect of privacy.  
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Chapter 4: Results 
 
4.1. Description of study participants 
The survey included 150 (3%) of the almost 5000 female students who were registered at the 
university in 2009.  
The mean age of the respondents was 22 years (standard deviation = 2.3 years). Most 
respondents were South African (70.7%) and Black (88%). Most respondents (79.3%) were 
senior students (i.e. 2nd, 3rd and 4th year students in their undergraduate degrees). 
 
Table 6: Demographic characteristics 
Age  
18 – 20  
21 – 24 
25 - 30 
Frequency 
37 
87 
26 
Percentage 
24.7 
58.0 
17.3 
Race  
Black 
Colored 
Asian/Indian 
White 
  
132 
8 
6 
4 
88.0 
5.3 
4.0 
2.7 
Nationality  
South African 
Non South African 
  
106 
44 
70.7 
29.3 
Year of Study 
 
 
 
Faculty                    
 
First 
Second 
Third 
Fourth 
Postgraduate 
 
Education 
Law 
Management and Commerce 
Science and Agriculture 
Socials Science and Humanities 
 
  
31 
66 
34 
12 
7 
 
30 
30 
30 
30 
30 
20.7 
44.0 
22.7 
8.0 
4.7 
 
20.0 
20.0 
20.0 
20.0 
20.0 
 
 
4.2 Sexual behavioral characteristics 
Most respondents reported to be in a relationship (71.3%) and being sexually active (71.3%). 
More than a third of sexual active respondents (37.4%) indicated that they had more than one 
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sexual partner in the past 6 months. More than half of the sexually active participants (60%) 
indicated that they had used a condom in their last sexual encounter. 
Table 7: Sexual and Behavioral Characteristics 
 Frequency Percentage 
In a relationship 107 71.3 
Sexually active 107 71.3 
Had more than 1 sexual partner in the last 6months  40 37.4 
Used a condom at last sexual encounter  65 60.0 
 
4.3. Awareness and knowledge about HPV  
Few study participants (22.7%) had ever heard of the Human Papilloma Virus (HPV); 
whereas most had heard about cancer of the cervix (90%) and the Pap smear (70%) (Table 8). 
Media (electronic and print) was the most common source of information reaching 58% of 
respondents. Health care institutions ranked the second (25.2%), followed by family and 
friends (25.2%). 
 
Table 8: Awareness of HPV  
 Frequency Percentage 
Awareness 
                HPV 
                 Cancer of the cervix 
                 Pap smear 
 
  34 
135 
105 
 
     22.7 
     90.0 
     70.0 
Source of information   
                   Media  81 58.3 
                   Family and friends  23 16.5 
                   Health care providers  35 25.2 
 
The knowledge was generally limited with none of the participants being able to answer all 
11 questions correctly. The mode score was 4 and median 4. Less than 5% (7) got 75% of 
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questions correct; and 22% got none correct. Most respondents (72%) were not sure about the 
association between HPV and Herpes (that HPV can cause Herpes genital infection); only 
9.3% gave the correct answer. On the other hand, 67.3% of respondents knew that there was a 
link between HPV and cancer of the cervix. Further, 43% of respondents were aware of the 
link between HPV and genital warts.  
 
Table 9: Knowledge about HPV 
Question         Percentage who got it correct 
HPV can cause herpes       9.3% 
Genital warts are caused by HPV     43.3% 
HPV can cause CA cervix      67.3% 
If the Pap smear is normal, then you don’t have HPV  14.0% 
Changes in Pap smear may indicate HPV    28.7% 
A negative test for HPV means you don’t have HPV  10.0% 
Most people with HPV have no visible signs or symptoms  38.7% 
I can transmit HPV even if I don’t have symptoms   39.3% 
Having one type of HPV means you can’t acquire new types 33.3% 
 
 
Awareness of the HPV vaccine 
Less than a third (32%) of respondents knew that a vaccine existed to prevent HPV and 
cervical cancer, and only 22% (33) of the study participants were aware that the vaccine is 
available in the country.  
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0%
50%
100%
A vaccine exist to 
prevent 
HPV/cancer of the 
The vaccine is 
available in South 
Africa
 
Figure 8: Awareness of availability of HPV vaccine 
4.4. Health related beliefs and uptake of HPV vaccine  
Risk perception for HPV among respondents was low with 41.3% (62) believing that they 
were at risk (Table 10). Most considered HPV infection and its consequences to be severe 
(78%), and believed that being vaccinated would effectively protect them against HPV 
(83.3%). Interestingly, most of the participants (89.7%) indicated a desire for more 
information on the HPV infection, cervical cancer and the HPV vaccine. 
Slightly over 80% (122) of the students were willing to be vaccinated if the vaccine was 
available. Vaccine uptake would be greatest among the study respondents if the vaccine can 
prevent cancer (71.3%) and both cancer and warts (93.3%). There was low interest (42.7%) 
in the vaccine, if it only prevented warts. 
More clients (70%) preferred to be vaccinated with once off dose than two doses over a three 
month period (28%). Similarly, a greater percentage of the participants (78%) would opt for a 
vaccine administered free of charge than when it is sold for R500 (22%).  
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Table 10: Health related beliefs and vaccine uptake 
       Frequency  Percentage 
Believe they are at risk of HPV infection   62   41.3 
Believe HPV infection is severe   117   78.6 
Believe that the HPV vaccine is effective  125   83.3 
Would want to get more education about HPV 147   89.7 
Would opt to be vaccinated if: 
 Available to them    122   81.3 
 It prevents warts only     64   42.7 
 It prevents cancer only   107   71.3 
 It prevents both    140   93.3 
 1 dose, once off    106   70.7 
 2 doses, three months apart    42   28.0 
 Vaccine is free of charge   117   78.0 
 Vaccine costs R500     64   42.2 
 Recommended by a doctor   126   84.0 
 Recommended by spouse/family/friend  88   58.7 
    
 
A doctor’s recommendation for the vaccine would result in higher potential vaccine uptake 
(84%); although many indicated that a recommendation from the spouse, family or friend 
would motivate them to be vaccinated (58.7%). 
4.5. Predictors of vaccine uptake  
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Being aware of the existence of a Pap smear and having more knowledge about HPV were 
associated with a four (OR = 3.54 [95% CI: 1.51-8.27]) and three-fold (OR =2.94 [95% CI: 
1.23-7.02]) increase, respectively, in odds of being willing to be vaccinated (P=0.003 and 
0.01 respectively). Those who believed HPV and its consequences to be severe were 
observed to be five times (OR=5.42 [2.23-13.2]) more willing to be vaccinated (P= 0.0002). 
Individuals who believed that the vaccine was effective were ten times (OR=10.09 [95% CI: 
3.84-16.5]) more willing to be vaccinated, when compared to those who did not believe the 
vaccine was effective (P=0.0000).  
However, being in a relationship, sexually active, having more than 1 sexual partner, using a 
condom at last sexual encounter and being aware of cancer were not significantly associated 
with opting for vaccination. 
Table 11: Simple Logistic Regression 
Predictors     Odds Ratio 95%  CI  P-Value 
Sexual Behavior 
Being in a relationship    2.20  0.94-5.16  0.06 
Being sexual active     0.64  0.24-1.72  0.38 
Having >1 partner in past 6 months  0.68  0.29-1.63  0.39 
Used a condom at last sex   1.04  0.41-2.61  0.94 
Awareness and knowledge about HPV  
Aware of Cancer of the cervix   2.43  0.76-7.79  0.13 
Aware of HPV     1.96  0.63-6.09  0.28 
Aware of PAP smear     3.54  1.51-8.27  0.003 
Has higher knowledge about HPV  2.94  1.23-7.02  0.01 
Health Beliefs 
Believe to be at risk of HPV infection 1.99  0.81-5.16  0.13 
Believe that HPV infection can be severe 5.42  2.23-13.2  0.0002  
Believe that the HPV vaccine is effective 10.09  3.84-16.5  0.0000 
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Table: 12: Multivariate Logistic Regression 
Predictors     Odds Ratio 95%  CI  P-Value 
Believe that vaccine is effective  7.30  2.52-21.1  0.0002 
Has higher knowledge about HPV  1.93  0.67-5.55  0.22 
Aware of Pap smear    1.90  0.63-5.80  0.26 
Believe that HPV can be severe  2.16  0.72-6.48  0.17 
 
Table 12 above displays the results of multivariate logistic regression. Only the belief that the 
vaccine would be effective was statistically significant in predicting those clients that would 
opt to be vaccinated when accounting for knowledge about HPV, awareness of pap smear 
and the belief that HPV or its consequences can be severe (P= 0.0002). Individuals who 
believed that HPV would be effective were seven times (OR=7.30 [2.52-21.10]) more likely 
to be vaccinated when compared to those who did not believe the vaccine was effective.  
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Chapter 5: Discussion  
5.1. Introduction 
This chapter presents the key results of this study in relation to the objectives as well as to the 
findings of similar studies whose results have been published elsewhere.  
5.2. Representativeness of study sample 
The racial distribution of the sample was similar to that of the university population in 2008 
and in both cases; black students constituted almost 90% of the population (see fig. 2 and 
table 6). It was also observed from table 6, that undergraduate students constitute the majority 
(95%) of the enrolment, which again compares well with the 2008 enrolment as shown in fig. 
3. The minor differences could be explained by the fact that enrolment differ slightly year. 
This suggests that the sample was representative of the study population. 
The study revealed that about 70% of the respondents were sexually active. This is similar to 
that reported (65%) by the recently published Higher Education South Africa (HESA) study 
(Higher Education HIV and AIDS Programme (HEAIDS), 2010). It was also observed in   
this study that 40% of the study participants indicated that they had not used a condom at 
their last sexual encounter and this is exactly the same figure reported by the HESA study 
(HEAIDS, 2010). It is also comparable to the findings of the 2008 Behavioral Survey which 
reported that 41.9% had not used a condom in their last sexual encounter (Shishana et al., 
2009). 
 However, the study found a higher percentage of individuals (37.4%) reporting that they had 
had more than 1 sexual partner I the 6 months prior to the study compared to those reported 
(6%) in the 2008 Behavioral Survey and HESA study (Shishana et al., 2009; HEAIDS, 
2010).  
 
5.3. Awareness and knowledge of HPV and vaccine 
In this study, 22.7% of the participants were found to be aware of HPV. This compares fairly 
well with findings from other studies. A study among sexually active female college students 
in the US found that 13% of them had heard of HPV. A systematic review of 60 studies on 
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awareness about HPV among females of diverse backgrounds reported a range of between 
13% and 93 (Klug et al., 2008).  
In contrast to low awareness of HPV, most (90%) of the participants were aware of cancer of 
the cervix. This could be due to the fact that HPV is a microbiological term and as such could 
be difficult for the non-clinical people (i.e. none medically trained) to recall when compared 
to cancer of the cervix which the general population would tend to recall more easily.  
The study showed that 70% of the respondents had heard of Pap smear. This is less than 95% 
that was reported for females who where staying in an urban district in Cape Town (Moodley 
et al., 2006). The difference could have arisen because the Cape Town study focused on 
women attending gynecological clinics and as such, they could have been more aware of pap 
smear due to their frequent contact with health workers. It was worrying to note that, in this 
study, more participants (58%) cited media as their source of information when compared to 
health care workers (25%). Similar findings were also reported (81% media versus 2% health 
care workers) in the aforementioned study by Moodley and colleagues (Moodley et al., 
2006).  
It was found in this study that the knowledge about HPV in general was poor. It was however 
encouraging to note that 67.3% of the students knew of the association between HPV and 
cancer of the cervix. This finding was almost the same (68%) as the one that was reported in 
a study of female university students at the Walter Sisulu University (formerly University of 
Transkei) (Buga, 1998). The finding of this study was higher than that found among female 
students in Iceland where only 34% of them knew of the association between the two 
(Gudmundsdottir et al., 2003). This is quite a positive sign since it is well known that HPV is 
necessary, though not sufficient, cause of cervical cancer, and that over 99% of cervical 
cancers world-wide result in genital infection with HPV (WHO, 2005; Munoz et al., 2006).  
However, this study highlighted the confusion between HPV and other sexually transmitted 
infections. For instance, only 9.3% of the students knew that HPV did not cause herpes. A 
similar finding was also observed in a study among female university students where 80% of 
them thought there was a link between HPV and herpes genitalis (Yacobi et al., 1999).  
This study found that less than a third of the respondents were aware of a vaccine to prevent 
HPV and cervical cancer, and even less (22%) were aware that the vaccine is available in the 
country. This is worrisome considering the fact that the  vaccine, which has a potential to 
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reduce the incident cancer cases by 68%, had been licensed for use in the country for one  
and half years before the study was commenced (Alliance for Cervical Cancer Prevention, 
2003; Harries et al., 2008).  
5.4. Vaccine acceptability 
This study showed that 80% percent of the respondents would opt to be vaccinated if it were 
available to them. These findings confirm the high levels of acceptability that has been 
documented in literature. In urban Turkey, acceptability of a HPV vaccine was even higher 
(96%) among a non-representative sample of women attending a gynecological clinic 
(Baykal et al., 2008). Locally, a qualitative study in the Western Cape Province among 
members of the community revealed that the need for a vaccine to prevent cancer resonated 
with all respondents, despite the overall poor knowledge about cancer of the cervix and its 
causal relationship with HPV (Harries et al., 2008). 
This study found that a greater proportion of study participants wanted a vaccine that would 
prevent both genital warts and cervical cancer. The finding confirmed what was reported by 
Hoover and colleagues that 97% of their respondents opted for a vaccine that prevents both 
diseases.  
 
5.5 Cues to action  
This study also revealed that more clients (70%) would prefer to be vaccinated with a once-
off dose than two doses over a three month period (28%).  This may have implications on the 
acceptability of the current vaccine which is to be administered via three doses three months 
apart with each dose costing R450; thus putting the total cost at R1350 (Medical News 
Today, 2008).  Moreover, the observation that a greater percentage of study participants 
(78%) would opt for a vaccine administered free of charge than when it is sold for R500 
(22%) suggest that something has to be done to make the vaccine affordable and hence 
accessible to the greater part of the populace.  
This study found that a doctor’s recommendation for the vaccine would result in a potential 
84% vaccine uptake whilst a recommendation from the spouse, friend or family of the study 
respondents would lead to about 60% uptake. Such findings have also been confirmed in 
studies done elsewhere. For instance, physician’s endorsement of a vaccine has been 
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identified as an important catalyst for vaccine acceptance (Zimet et al., 2005). In a similar 
way, a number of studies report that higher acceptability of the vaccine was found among 
subjects who thought that their doctors would recommend it (Boehner et al., 2004; Dempsey 
et al., 2006; Khan et al., 2003). This finding lends support to the notion that among various 
possible cues to action, physician recommendation is likely to be a key ingredient of 
successful HPV vaccination programs. This is because physicians may be uniquely 
persuasive in addressing perceived barriers, for example by initiating a conversation with 
patients about their concerns, clarifying any misunderstandings and recommending the 
vaccine. 
 
5.6 Health Belief Model constructs as predictors of vaccine uptake 
HBM constructs have been reported to be predictors of potential vaccine uptake (Becker, 
1974; Brewer et al., 2004). A number of studies documented that higher perceived risk of 
HPV infection was associated with higher vaccine acceptability (Boehner et al., 2003; 
Friedman and Sherpard, 2006; Olshen et al., 2005). However in this study it was found that 
higher perceived risk of HPV infection was not statistically significantly associated with 
higher vaccine acceptability.  
The study also found that perceived severity is significant predictor of willingness to be 
vaccinated. This finding is in contradiction which the documented literature which state that 
perceived severity was not related to vaccine acceptability (Boehner et al., 2003; Khan et al., 
2003; Dempsey et al., 2006). This difference could have arisen due to the fact these studies 
were done in the western world where the beliefs could potentially differ from the 
predominantly this African group that I conducted my study on. 
In this study, it was found that perceived vaccine effectiveness was associated with higher 
vaccine effectiveness. This variable remained statistically significant even when all the 
variables were put into a multivariate regression model. This confirmed the findings in 
previous studies (Davis et al., 2004; Dempsey et al., 2006). It was interesting to note that this 
study confirmed the reports of literature that perceived vaccine effectiveness as the most 
important attribute of an acceptable vaccine, as it had the highest Odds Ratio among all the 
other variables (Zimet et al., 2005). By this line of reasoning, it is plausible that HPV vaccine 
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programs in South Africa should emphasize the high likelihood of HPV infection, high 
vaccine effectiveness, and physicians' recommendations. 
 
5.7. Other predictors of vaccine uptake 
This study found that those who had higher knowledge of HPV and vaccine were almost 
three times more likely to opt for the vaccine compared to those with poor knowledge. 
However, this finding contradicts other studies that found HPV vaccine acceptability to be 
high despite generally low levels of knowledge about HPV (Harries et al., 2008; Wong, 
2008). The findings of the two studies are quite surprising since one would presume that 
limited knowledge and awareness of HPV may make it difficult for some people to discuss 
HPV vaccine acceptability (Friedman and Shepeard, 2006; Olshen et al., 2005). This issue 
should be pursued in future research. 
It was noted in this study that being sexually active and in particular having more than sexual 
partner in the six months prior the study was not significantly associated with higher vaccine 
acceptability as suggested in literature (Fazekas et al., 2008; Marshall et al., 2007). Future 
research should explore the reason for these differences. 
 
5.8. Outcomes of Hypotheses testing 
 
The discussions in sections above show that the following were the outcomes:  
 
 Intention to be vaccinated/Perceived severity. 
 
H1: Female students were more likely to be vaccinated if they perceived the infection or its 
consequences to be severe. 
 
Intention to be vaccinated/Perceived susceptibility. 
 
H2: Female students were more likely to be vaccinated if they perceived that they were at 
risk of infection. 
 
Intention to be vaccinated/Perceived effectiveness. 
 
H3: Female students were more likely to be vaccinated if they perceived that the vaccine is 
effective in preventing the infection and its consequences. 
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Chapter 6: Conclusions and Recommendations 
6.1. Strengths of the study 
This study is unique in that it was one of the first studies to apply the Health Belief Model to 
HPV vaccine acceptability among college students in South Africa. I was able to survey a 
random sample of female students from the university, thereby increasing the generalizabilty 
of the findings to the university female student body. A few of the studies on this topic found 
in the literature on South Africa used convenience samples to collect data. This study utilized 
a questionnaire to collect data. The fact that a questionnaire can be standardized increases the 
reliability, comparability and precision of data from one region or time frame to another. 
Also, the fact that it was self-administered minimized the issues of confidentiality which were 
particularly important in the case of sensitive issues like sexual activity. This increased the 
likelihood of respondents answering candidly because the anonymity and confidentiality of 
their responses were ensured. Its close ended nature meant that exact responses were obtained 
and thus, easy to code, analyze and interpret. 
 
6.2. Limitations of the study 
It is important to note that there may be several limitations to the generalizability of the 
current findings. Firstly, because the students were made aware of the nature of the survey 
before they accessed it, those who participated may have chosen to do so because they had a 
personal interest in the knowledge about HPV, and those who were not comfortable 
answering questions about their sexuality and health beliefs regarding a sexually transmitted 
infection may have avoided taking the survey. Secondly, due to the study design, students 
who had a lower frequency of accessing their e-mails were likely to be under-represented 
thus; the findings may not be generalizable to other students in other centres of tertiary 
education across the country. 
Thirdly, because all of the data were collected via self-report, participants may not have 
answered all of the questions truthfully due to recall bias. Information bias may also be 
present that occurred, as responses to questions 5, 6, 7 and 8 in section A of the questionnaire 
may have been influenced by social desirability. It must however, be pointed out that 
questions used for self-declaration of intimate or socially stigmatized behaviors were 
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questions that have been used and validated in other health and social surveys dealing with 
similar issues (McPartland et al., 2005). 
Moreover, questionnaires are prone to a number of non-sampling errors. They suffer from 
cultural re-interpretation. This is an observation that people do not respond to the formal 
content of a question, but to the meanings (associations and connotations) which they have. 
For instance, in one study, the question whether one had ever heard about abortion was 
interpreted as looking for whether one had a personal experience of abortion (Stone and 
Campbell, 1984). Hence in this case, asking whether a study participant had heard of HPV 
infection could have been interpreted as asking whether they ever had the infection.  
 
Fourthly, the study only assessed intended acceptance of HPV vaccination hypothetically, 
and this may not map directly on to actual acceptance of the vaccine. However, the first pilot 
study done in the United Kingdom on uptake of the HPV vaccine in 12-13 year old girls, 
found that levels of uptake were broadly consistent with previous hypothetical studies 
(Waller et al., 2004). Moreover, I used a single-item measure to assess acceptability to keep 
the questionnaire short and simple but also because when adolescent girls are invited to have 
HPV vaccination, they will have to make a dichotomous decision (i.e. to accept or not accept 
the invitation). However it is often argued that single item measures can have a large error 
(Burak and Meyer, 1997). 
 
6.3. Main findings of study 
This study described the sexual behaviour characteristics, knowledge of HPV 
infection/vaccine and factors associated with vaccine acceptability among female students at 
a university in South Africa. 
The following patterns of sexual behaviour were noted: 
• About 70 % of them reported that they were sexually active. 
• At least 40 % of them reported that they had not used a condom at last sexual 
encounter. 
• 37% of them stated that they had had more than 1 sexual partner in the last 6 months.  
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Awareness and knowledge on HPV/vaccine were generally poor and marked by the fact that: 
• Only 22% of them were aware of HPV. 
• Greater proportions were aware of cancer of the cervix (90%) and Pap smear (70%). 
• Health care workers were stated as sources of information by 25% of students. 
• 67% of them knew the association between HPV and cancer of the cervix. 
• Only 32% of them knew that a vaccine against HPV has been developed. 
• Only 22% knew that the HPV vaccine is available in the country. 
The following factors were noted on vaccine acceptability: 
• 80% stated that they would be willing to be vaccinated. 
• A greater proportion preferred a vaccine that would prevent both warts and cancer. 
• More than 70% of the students would opt for a vaccine that was free of charge and 
given as a single once off dose. 
• More respondents would opt to be vaccinated if it’s recommended by their physician 
(84%) than when it’s a family member or friend (58%). 
• Perceived vaccine effectiveness was the most (5 times more likely to opt for the 
vaccine) important attribute of an acceptable vaccine.  
• Perceived HPV severity was associated with 3.5 times more potential vaccine uptake.  
• Perceived risk of infection was associated with 1.7 times more uptake. 
• Higher knowledge of HPV was associated with higher vaccine acceptability. 
• It was noted that HBM constructs are associated with vaccine acceptability. 
 
6.4. Recommendations for strategies to be considered during the introduction and 
propagation of public health care system based HPV vaccination in South Africa. 
Based on the aforementioned findings of this study the following recommendations can be 
drawn. 
• There is need to embark on behaviour modification education among university 
students, given the high prevalence of risky sexual behaviours reported in this study. 
• A lot still needs to be done in educating the population about HPV, cancer of the 
cervix and HPV vaccine, in view of the poor knowledge demonstrated by university 
students whom, because of their potential to attain higher education and social status 
one could assume they know better than the ordinary women in the community. 
• Health care institutions and workers should take the centre stage in providing this 
information because have been to be shown in this study to have more positive 
influence and also have the technical know how to correct any misconceptions which 
have been shown to be prevalent in this study. 
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• There is urgent need to review the cost of the vaccine, or make it available in the 
public health sector so that it will be accessible to a greater number of clients. 
Otherwise, vaccine uptake may be harmed by the existing disparities in health care 
access and thus, widen rather than narrow existing disparities in cervical cancer 
deaths among South African women. 
• The findings about factors that affect vaccine acceptability lends support to the notion 
that for the vaccine marketing strategy to be effective, it should educate the women on 
HPV, emphasising their susceptibility (i.e risk) to contracting this infection which has 
severe (i.e. severity) consequences and also about the vaccine effectiveness in 
preventing HPV and cervical cancer including its potential impact if adopted on a 
wide scale. 
 
6.5. Recommendations for future research 
• More studies are urgently needed to address the paucity of HPV vaccine acceptability 
research and literature in developing countries and in particular, Southern Africa.  
• This study focused on female students at one university and as such, may not be 
generalizable to females in South Africa. It is therefore necessary to embark on   a 
wider research to target the ordinary population in the country. 
• This study assessed hypothetical vaccine acceptability. It would be necessary to have 
studies that report actual acceptability during the early implementation of wide spread 
vaccination campaigns in the near future. 
• Future studies may explore the effects of knowledge levels, sexual activity and having 
more sexual partners on vaccine acceptability. 
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Appendix 1: Consent Form 
 
UNIVERSITY OF THE WESTERN CAPE 
School of Public Health 
Private Bag X17 ● BELLVILLE ● 7535 ● South Africa 
Tel: 021- 959 2809, Fax: 021- 959 2872 
 
CONSENT FORM 
 
Title of Research Project: Human Papilloma Virus (HPV) Infection Awareness and 
Knowledge among Female Students at a South African University and their 
Intention to Receive an HPV Vaccine in 2009 
. 
The study has been described to me in language that I understand and I freely and voluntarily 
agree to participate. My questions about the study have been answered. I understand that my 
identity will not be disclosed and that I may withdraw from the study without giving a reason at 
any time and this will not negatively affect me in any way. 
 
 
Participant’s name……………………….. 
 
Participant’s signature………………………………. 
 
Date……………………… 
 
Should you have any questions regarding this study or wish to report any problems you have 
experienced related to the study, please contact the study coordinator: 
 
 
 
Study Coordinator’s Name: Dr. Brian Van Wyk 
 
University of the Western Cape 
 
Private Bag X17, Bellville 7535 
 
Telephone: (021)959-2173 
 
Cell: 082 804 9055 Email: bvanwyk@uwc.ac.za 
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Appendix 2: Information Sheet 
UNIVERSITY OF THE WESTERN CAPE 
School of Public Health 
Private Bag X17 ● BELLVILLE ● 7535 ● South Africa 
 
Participant Information Sheet 
 
Dear Student: You are invited to participate in the research project “Knowledge and 
Awareness of HPV and vaccine among university students”. 
 
Why are we doing this? 
The aim of the project is to determine what students know about Human Papilloma Virus (HPV) 
which is a sexually transmitted virus, cancer of the cervix and to ascertain their intention to take 
up an HPV vaccine. 
 
Who is the researcher?  
The study is being conducted by, Dr A.Chikandiwa, as a partial fulfilment of a Masters Degree in 
Public Health, at the University of the Western Cape, South Africa. 
 
What do I expect from you in this study?  
Attached to this letter is a questionnaire that contains 27 questions which you will be asked to 
respond to. It will take you about 10 mins to complete. Please look over the questionnaire and, if 
you choose to answer it, please sign in the consent form provided. By signing, it will be 
understood that you have consented to participate in the project, and that you consent to 
publication of the results of the project with the understanding that anonymity will be preserved. 
Your participation is voluntary and there is no penalty if you do not participate. However, I urge 
you to participate and complete all questions. You will be given a brochure which has general 
knowledge on HPV and cancer of the cervix at the end of the survey and a break fast voucher as a 
token of my appreciation of your participation. 
 
Anticipated benefits of the study to society:  
The results of this survey will inform the department of health in developing appropriate future 
preventive strategies against HPV and cancer of the cervix. 
 
What will be done to ensure confidentiality?  
This is an entirely anonymous questionnaire, and so your responses will not be identified with 
you personally in any way. To ensure security, the questionnaires will be kept under lock and 
key. They will be destroyed after data entry. Data will be stored electronically in a database on a 
secured server and access is restricted by password to the researcher. 
 
 
Yours Sincerely, Dr. Admire T Chikandiwa. 
Please keep this information sheet and if at any stage you have any queries or concerns regarding 
your participation in the study, please contact me on: Email: 
addychiks@doctor.com Cell: 0027 719 698 643 
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Appendix 3: Questionnaire 
HPV Questionnaire 
SECTION A: Socio-demographic characteristics 
 
Please tell me a little bit about your self 
 
1) Current age in completed years._______________ 
                                                                                            
2) Race/Ethnicity and nationality (please tick any two that apply).    
                                   
Black White Colored Asian/Indian South African Non-South African 
        
 
3) Current level of study in the University (please tick one). 
 
4) Faculty in which you in (please tick one that applies). 
Education Law Management & Commerce  Science & Agriculture Social & Humanities 
     
 
5) Are you in a relationship?___YES_ _____NO_ ____ 
 
6) Are you sexually active?___ YES_ _____NO_ ____                                             
 
 
7) How many sexual partners have you had in the past 12 months? 
 
 
8) Did you use a condom at your last sexual encounter?__ YES_ ____NO_ ___ 
 
SECTION B: HPV/VACCINE AWARENESS AND KNOWLEDGE 
HPV is a sexually transmitted virus.  
 
9) Have you ever heard of Human Papilloma Virus or HPV? __YES_ ___NO_ ___                               
                  
 
10) Have you ever heard of cancer of the cervix/mouth of the womb? __ YES_ ___ NO_ ___ 
 
 
11) Have you ever heard of a Pap smear/Test?                                   __ YES_ ___ NO _ ___ 
 
12) If any of your answers to the three questions above is yes indicate your source of 
information by ticking in the appropriate box below: 
 
Media (TV, Radio, 
newspapers, internet) 
Family members or 
friends 
Health care providers 
1st year 2nd year 3rd year 4th year Postgraduate 
     
0 1 2-3 4-5 5+ 
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13) HPV knowledge: 
Question True False Not 
Sure 
A: HPV can cause herpes. 
 
   
B: Genital warts are caused by HPV. 
 
   
C: HPV can cause cancer of the cervix. 
 
   
D: If a woman’s pap smear is normal, she does not have HPV. 
 
   
E: Changes in a pap smear may indicate that a woman has HPV. 
 
   
F: A negative test for HPV means that you do not have HPV. 
 
   
G: Most people with HPV have no visible signs or symptoms.  
 
   
H: I can transmit HPV to my partner even if I do not have symptoms. 
 
   
I: Having one type of HPV means that you cannot acquire new types. 
 
   
J: A vaccine exists to prevent HPV infection/cancer of the cervix. 
 
   
K: The vaccine is available in South Africa. 
 
   
 
SECTION C: Health related beliefs. 
 
HPV is a sexually transmitted virus that can cause genital warts or cancer of the cervix. 
The following are specific questions about an HPV vaccine that has been developed to 
prevent HPV Infection, genital warts and cancer of the cervix. I am interested in how 
people might feel about this vaccine.  So for now, please pretend the vaccine is available 
 
14) How likely do you think it is that you will get infected with HPV? 
 
Very likely Fairly likely Not likely Very unlikely 
    
 
15) How severe do you think it would be to have Human Papilloma Virus infection? 
 
Very severe Fairly severe Not severe Not at all severe 
    
 
16) How likely do you think that being vaccinated against HPV will help reducing your 
chances of getting infected? 
 
Very likely Fairly likely Not likely Very  unlikely 
    
 
 
 
 
84 
 
17) Would you want to be vaccinated to prevent HPV infection and cancer of the cervix or 
cancer of the womb? _ ___YES ____ NO_____.                        
 
How likely would you get the vaccine if:  
 
 More 
likely  
Likely  Unlikely  More 
unlikely  
18. It prevented cervical cancer in women, but 
did not prevent genital warts  
    
19. It prevented genital warts, but did not 
prevent cervical cancer in women  
    
20. It prevented both genital warts and cervical 
cancer  
    
 
Would the following potential features make you less likely or more likely to get an HPV 
Vaccine? 
 
 
27: Do you intent to get more education on HPV and vaccine?_ ____ YES_ ____ NO___              
       
That’s it! You’re done! I appreciate your willingness to answer these questions! 
 
 
 
 Much less 
likely to 
get  
Less 
likely 
 More 
likely 
Much 
more 
likely 
21. Having to pay R500 for the HPV vaccine 
my self.  
 
    
22. Having the HPV vaccine for free.  
 
     
23. If the HPV vaccine was recommended to 
me by my doctor  
 
    
24. If the HPV vaccine was recommended to 
me by my spouse/partner/parents/family 
members 
 
    
25. The HPV vaccine was given as three 
doses 3 months apart.  
 
    
26. The HPV vaccine was given in as a single 
dose. 
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